|
Patent 6124090: Nucleic acid amplification using single primer
(CHEMISTRY: MOLECULAR BIOLOGY AND MICROBIOLOGY : MEASURING OR TESTING PROCESS INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITION OR TEST STRIP THEREFORE; PROCESSES OF FORMING SUCH COMPOSITION OR TEST STRIP : Involving nucleic acid :)
Patent 6124091: Cell growth-controlling oligonucleotides
(CHEMISTRY: MOLECULAR BIOLOGY AND MICROBIOLOGY : MEASURING OR TESTING PROCESS INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITION OR TEST STRIP THEREFORE; PROCESSES OF FORMING SUCH COMPOSITION OR TEST STRIP : Involving nucleic acid :)
Patent 6124092: Multiplex polynucleotide capture methods and compositions
(CHEMISTRY: MOLECULAR BIOLOGY AND MICROBIOLOGY : MEASURING OR TESTING PROCESS INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITION OR TEST STRIP THEREFORE; PROCESSES OF FORMING SUCH COMPOSITION OR TEST STRIP : Involving nucleic acid :)
Patent 6124093: Process for reducing the formation of artifacts during transcription of ribonucleic acids to deoxynucleic acids
(CHEMISTRY: MOLECULAR BIOLOGY AND MICROBIOLOGY : MEASURING OR TESTING PROCESS INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITION OR TEST STRIP THEREFORE; PROCESSES OF FORMING SUCH COMPOSITION OR TEST STRIP : Involving nucleic acid :)
Patent 6124094: Zoogloeal and hyphomicrobium spp. nucleic acids
(CHEMISTRY: MOLECULAR BIOLOGY AND MICROBIOLOGY : MEASURING OR TESTING PROCESS INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITION OR TEST STRIP THEREFORE; PROCESSES OF FORMING SUCH COMPOSITION OR TEST STRIP : Involving nucleic acid :)
Patent 6124095: Human nucleotide pyrophosphohydrolase-2
(CHEMISTRY: MOLECULAR BIOLOGY AND MICROBIOLOGY : MEASURING OR TESTING PROCESS INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITION OR TEST STRIP THEREFORE; PROCESSES OF FORMING SUCH COMPOSITION OR TEST STRIP : Involving nucleic acid :)
Patent 6124097: Stable gene amplification in chromosomal DNA of prokaryotic microorganisms
(CHEMISTRY: MOLECULAR BIOLOGY AND MICROBIOLOGY : MEASURING OR TESTING PROCESS INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITION OR TEST STRIP THEREFORE; PROCESSES OF FORMING SUCH COMPOSITION OR TEST STRIP : Involving nucleic acid :)
Patent 6124098: Rapid detection of antibiotic resistance in mycobacterium tuberculosis
(CHEMISTRY: MOLECULAR BIOLOGY AND MICROBIOLOGY : MEASURING OR TESTING PROCESS INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITION OR TEST STRIP THEREFORE; PROCESSES OF FORMING SUCH COMPOSITION OR TEST STRIP : Involving nucleic acid :)
Patent 6124099: Method for placing a photo-cross-linking agent at specific internal sites within the sequence of synthetic strands of ribonucleic acids
(CHEMISTRY: MOLECULAR BIOLOGY AND MICROBIOLOGY : MEASURING OR TESTING PROCESS INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITION OR TEST STRIP THEREFORE; PROCESSES OF FORMING SUCH COMPOSITION OR TEST STRIP : Involving nucleic acid :)
Patent 6124100: Diagnostic method and kit for neuropsychiatric diseases using trinucleotide repeats sequence
(CHEMISTRY: MOLECULAR BIOLOGY AND MICROBIOLOGY : MEASURING OR TESTING PROCESS INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITION OR TEST STRIP THEREFORE; PROCESSES OF FORMING SUCH COMPOSITION OR TEST STRIP : Involving nucleic acid :)
Patent 6124101: Recombinant thrombin receptor and related pharmaceuticals
(CHEMISTRY: MOLECULAR BIOLOGY AND MICROBIOLOGY : MEASURING OR TESTING PROCESS INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITION OR TEST STRIP THEREFORE; PROCESSES OF FORMING SUCH COMPOSITION OR TEST STRIP : Involving antigen-antibody binding, specific binding protein assay or specific ligand-receptor binding assay :)
Patent 6124102: Methods for determining receptor-ligand binding using probe arrays
(CHEMISTRY: MOLECULAR BIOLOGY AND MICROBIOLOGY : MEASURING OR TESTING PROCESS INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITION OR TEST STRIP THEREFORE; PROCESSES OF FORMING SUCH COMPOSITION OR TEST STRIP : Involving antigen-antibody binding, specific binding protein assay or specific ligand-receptor binding assay :)
Patent 6124103: Arrangement and method of examining hydrophilic macromolecules in an aqueous solution
(CHEMISTRY: MOLECULAR BIOLOGY AND MICROBIOLOGY : MEASURING OR TESTING PROCESS INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITION OR TEST STRIP THEREFORE; PROCESSES OF FORMING SUCH COMPOSITION OR TEST STRIP : Involving antigen-antibody binding, specific binding protein assay or specific ligand-receptor binding assay :)
Patent 6124104: Chromosome 13-linked breast cancer susceptibility gene
(CHEMISTRY: MOLECULAR BIOLOGY AND MICROBIOLOGY : MEASURING OR TESTING PROCESS INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITION OR TEST STRIP THEREFORE; PROCESSES OF FORMING SUCH COMPOSITION OR TEST STRIP : Involving antigen-antibody binding, specific binding protein assay or specific ligand-receptor binding assay : Involving a micro-organism or cell membrane bound antigen or cell membrane bound receptor or cell membrane bound antibody or microbial lysate :)
Patent 6124105: Method for detecting the presence of a mycobacterium species and a kit and antibodies for use therein
(CHEMISTRY: MOLECULAR BIOLOGY AND MICROBIOLOGY : MEASURING OR TESTING PROCESS INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITION OR TEST STRIP THEREFORE; PROCESSES OF FORMING SUCH COMPOSITION OR TEST STRIP : Involving antigen-antibody binding, specific binding protein assay or specific ligand-receptor binding assay : Involving a micro-organism or cell membrane bound antigen or cell membrane bound receptor or cell membrane bound antibody or microbial lysate : Animal cell : Tumor cell or cancer cell :)
Patent 6124106: Method for detecting cancers
(CHEMISTRY: MOLECULAR BIOLOGY AND MICROBIOLOGY : MEASURING OR TESTING PROCESS INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITION OR TEST STRIP THEREFORE; PROCESSES OF FORMING SUCH COMPOSITION OR TEST STRIP : Involving antigen-antibody binding, specific binding protein assay or specific ligand-receptor binding assay : Involving a micro-organism or cell membrane bound antigen or cell membrane bound receptor or cell membrane bound antibody or microbial lysate : Animal cell : Tumor cell or cancer cell :)
Patent 6124107: Assay for marker of human polymorphonuclear leukocyte elastase activity
(CHEMISTRY: MOLECULAR BIOLOGY AND MICROBIOLOGY : MEASURING OR TESTING PROCESS INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITION OR TEST STRIP THEREFORE; PROCESSES OF FORMING SUCH COMPOSITION OR TEST STRIP : Involving antigen-antibody binding, specific binding protein assay or specific ligand-receptor binding assay : Involving a micro-organism or cell membrane bound antigen or cell membrane bound receptor or cell membrane bound antibody or microbial lysate : Animal cell : Leukocyte (e.g., lymphocyte, granulocyte, monocyte, etc.) :)
Patent 6124108: Protein biomarker for mustard chemical injury
(CHEMISTRY: MOLECULAR BIOLOGY AND MICROBIOLOGY : MEASURING OR TESTING PROCESS INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITION OR TEST STRIP THEREFORE; PROCESSES OF FORMING SUCH COMPOSITION OR TEST STRIP : Involving antigen-antibody binding, specific binding protein assay or specific ligand-receptor binding assay : To identify an enzyme or isoenzyme : Bacteria or actinomycetales)
Patent 6124109: System for qualitatively and/or quantitatively analyzing preferably biological substances using enhanced chemiluminescence, and method and
(CHEMISTRY: MOLECULAR BIOLOGY AND MICROBIOLOGY : MEASURING OR TESTING PROCESS INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITION OR TEST STRIP THEREFORE; PROCESSES OF FORMING SUCH COMPOSITION OR TEST STRIP : Involving antigen-antibody binding, specific binding protein assay or specific ligand-receptor binding assay : Assay in which an enzyme present is a label : Heterogeneous or solid phase assay system (e.g., ELISA, etc.) : Escherichia coli)
Patent 6124110: Method for determining activated coagulation factors in plasma and plasma derivatives
(CHEMISTRY: MOLECULAR BIOLOGY AND MICROBIOLOGY : MEASURING OR TESTING PROCESS INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITION OR TEST STRIP THEREFORE; PROCESSES OF FORMING SUCH COMPOSITION OR TEST STRIP : Involving blood clotting factor (e.g., involving thrombin, thromboplastin, fibrinogen, etc.) : Assay in which an enzyme present is a label)
Patent 6124111: Method and an arrangement for measuring the amount/activity of catalase before or in connection with bleaching of preferably cellulose fibres
(CHEMISTRY: MOLECULAR BIOLOGY AND MICROBIOLOGY : MEASURING OR TESTING PROCESS INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITION OR TEST STRIP THEREFORE; PROCESSES OF FORMING SUCH COMPOSITION OR TEST STRIP : Involving oxidoreductase : Involving catalase : Involving phosphatase)
Patent 6124112: Method for the production of a fermented compost using bacteria, fungi and worms at controlled temperature
(CHEMISTRY: MOLECULAR BIOLOGY AND MICROBIOLOGY : MICRO-ORGANISM, TISSUE CELL CULTURE OR ENZYME USING PROCESS TO SYNTHESIZE A DESIRED CHEMICAL COMPOUND OR COMPOSITION : Process involving micro-organisms of different genera in the same process, simultaneously : Involving tissue sections)
Patent 6124113: Fermentative carotenoid production
(CHEMISTRY: MOLECULAR BIOLOGY AND MICROBIOLOGY : MICRO-ORGANISM, TISSUE CELL CULTURE OR ENZYME USING PROCESS TO SYNTHESIZE A DESIRED CHEMICAL COMPOUND OR COMPOSITION : Preparing compound containing a carotene nucleus (i.e., carotene) : Dehydrogenating; dehydroxylating)
Patent 6124114: Hemoglobins with intersubunit dislufide bonds
(CHEMISTRY: MOLECULAR BIOLOGY AND MICROBIOLOGY : MICRO-ORGANISM, TISSUE CELL CULTURE OR ENZYME USING PROCESS TO SYNTHESIZE A DESIRED CHEMICAL COMPOUND OR COMPOSITION : Recombinant DNA technique included in method of making a protein or polypeptide : Dehydrogenating; dehydroxylating)
Patent 6124115: Production and use of isolated type 5 17.beta.-hydroxysteroid dehydrogenase
(CHEMISTRY: MOLECULAR BIOLOGY AND MICROBIOLOGY : MICRO-ORGANISM, TISSUE CELL CULTURE OR ENZYME USING PROCESS TO SYNTHESIZE A DESIRED CHEMICAL COMPOUND OR COMPOSITION : Recombinant DNA technique included in method of making a protein or polypeptide : Dehydrogenating; dehydroxylating)
Patent 6124116: Rab proteins
(CHEMISTRY: MOLECULAR BIOLOGY AND MICROBIOLOGY : MICRO-ORGANISM, TISSUE CELL CULTURE OR ENZYME USING PROCESS TO SYNTHESIZE A DESIRED CHEMICAL COMPOUND OR COMPOSITION : Recombinant DNA technique included in method of making a protein or polypeptide : Dehydrogenating; dehydroxylating)
Patent 6124117: Polysaccharide binding fusion proteins and conjugates
(CHEMISTRY: MOLECULAR BIOLOGY AND MICROBIOLOGY : MICRO-ORGANISM, TISSUE CELL CULTURE OR ENZYME USING PROCESS TO SYNTHESIZE A DESIRED CHEMICAL COMPOUND OR COMPOSITION : Recombinant DNA technique included in method of making a protein or polypeptide : Dehydrogenating; dehydroxylating)
Patent 6124118: Receptor recognition factors, protein sequences and methods of use thereof
(CHEMISTRY: MOLECULAR BIOLOGY AND MICROBIOLOGY : MICRO-ORGANISM, TISSUE CELL CULTURE OR ENZYME USING PROCESS TO SYNTHESIZE A DESIRED CHEMICAL COMPOUND OR COMPOSITION : Recombinant DNA technique included in method of making a protein or polypeptide : Dehydrogenating; dehydroxylating)
Patent 6124119: mecB
(CHEMISTRY: MOLECULAR BIOLOGY AND MICROBIOLOGY : MICRO-ORGANISM, TISSUE CELL CULTURE OR ENZYME USING PROCESS TO SYNTHESIZE A DESIRED CHEMICAL COMPOUND OR COMPOSITION : Recombinant DNA technique included in method of making a protein or polypeptide : Dehydrogenating; dehydroxylating)
Patent 6124120: Multiple displacement amplification
(CHEMISTRY: MOLECULAR BIOLOGY AND MICROBIOLOGY : MICRO-ORGANISM, TISSUE CELL CULTURE OR ENZYME USING PROCESS TO SYNTHESIZE A DESIRED CHEMICAL COMPOUND OR COMPOSITION : Preparing compound containing saccharide radical : Preparing nitrogen-containing saccharide : N-glycoside : Nucleotide : Polynucleotide (e.g., nucleic acid, oligonucleotide, etc.) : Acellular exponential or geometric amplification (e.g., PCR, etc.) :)
Patent 6124121: Method for producing L-leucine
(CHEMISTRY: MOLECULAR BIOLOGY AND MICROBIOLOGY : MICRO-ORGANISM, TISSUE CELL CULTURE OR ENZYME USING PROCESS TO SYNTHESIZE A DESIRED CHEMICAL COMPOUND OR COMPOSITION : Preparing alpha or beta amino acid or substituted amino acid or salts thereof : Alanine; leucine; isoleucine; serine; homoserine : Utilizing surfactant fatty acids or fatty acid esters (i.e., having seven or more atoms))
Patent 6124122: Process for preparing optically pure (S)-3-hydroxy-.gamma.-butyrolactone
(CHEMISTRY: MOLECULAR BIOLOGY AND MICROBIOLOGY : MICRO-ORGANISM, TISSUE CELL CULTURE OR ENZYME USING PROCESS TO SYNTHESIZE A DESIRED CHEMICAL COMPOUND OR COMPOSITION : Preparing heterocyclic carbon compound having only O, N, S, Se, or Te as ring hetero atoms : Oxygen as only ring hetero atom : Containing five-membered hetero ring (e.g., griseofulvin, etc.) : Nucleotide)
Patent 6124123: UBCH7-like ubiquitin-conjugating enzyme
(CHEMISTRY: MOLECULAR BIOLOGY AND MICROBIOLOGY : ENZYME (E.G., LIGASES (6. ), ETC.), PROENZYME; COMPOSITIONS THEREOF; PROCESS FOR PREPARING, ACTIVATING, INHIBITING, SEPARATING, OR PURIFYING ENZYMES : Enzyme or microbial cell is immobilized on or in an organic carrier)
Patent 6124124: Oxidation in solid state of oxidizable galactose type of alchohol configuration containing polymer
(CHEMISTRY: MOLECULAR BIOLOGY AND MICROBIOLOGY : ENZYME (E.G., LIGASES (6. ), ETC.), PROENZYME; COMPOSITIONS THEREOF; PROCESS FOR PREPARING, ACTIVATING, INHIBITING, SEPARATING, OR PURIFYING ENZYMES : Oxidoreductase (1. ) (e.g., luciferase) : Acting on CHOH group as donor (e.g., glucose oxidase, lactate dehydrogenase (1.1)) : Enzyme or microbial cell is entrapped within the carrier (e.g., gel, hollow fibre))
Patent 6124125: AMP activated protein kinase
(CHEMISTRY: MOLECULAR BIOLOGY AND MICROBIOLOGY : ENZYME (E.G., LIGASES (6. ), ETC.), PROENZYME; COMPOSITIONS THEREOF; PROCESS FOR PREPARING, ACTIVATING, INHIBITING, SEPARATING, OR PURIFYING ENZYMES : Transferase other than ribonuclease (2.) : Transferring phosphorus containing group (e.g., kineases, etc.(2.7)) : Enzyme or microbial cell is entrapped within the carrier (e.g., gel, hollow fibre))
Patent 6124126: Complementary DNA for rice chitinase having lytic activity against moulds and bacteria, and vector containing said complementary DNA and
(CHEMISTRY: MOLECULAR BIOLOGY AND MICROBIOLOGY : ENZYME (E.G., LIGASES (6. ), ETC.), PROENZYME; COMPOSITIONS THEREOF; PROCESS FOR PREPARING, ACTIVATING, INHIBITING, SEPARATING, OR PURIFYING ENZYMES : Hydrolase (3. ) : Acting on glycosyl compound (3.2) : Ribonuclease (3.1.4))
Patent 6124127: Pectate lyase
(CHEMISTRY: MOLECULAR BIOLOGY AND MICROBIOLOGY : ENZYME (E.G., LIGASES (6. ), ETC.), PROENZYME; COMPOSITIONS THEREOF; PROCESS FOR PREPARING, ACTIVATING, INHIBITING, SEPARATING, OR PURIFYING ENZYMES : Lyase (4. ) : Acting on carbon to nitrogen bond other than peptide bond (3.5))
Patent 6124128: Long wavelength engineered fluorescent proteins
(CHEMISTRY: MOLECULAR BIOLOGY AND MICROBIOLOGY : MICRO-ORGANISM, PER SE (E.G., PROTOZOA, ETC.); COMPOSITIONS THEREOF; PROCES OF PROPAGATING, MAINTAINING OR PRESERVING MICRO-ORGANISMS OR COMPOSITIONS THEREOF; PROCESS OF PREPARING OR ISOLATING A COMPOSITION CONTAINING A MICRO-ORGANISM; CULTURE MEDIA THEREFOR : Bacteria or actinomycetales; media therefor : Transformants (e.g., recombinant DNA or vector or foreign or exogenous gene containing, fused bacteria, etc.) : Escherichia (e.g., E. coli, etc.) : T-cell or derivative)
Patent 6124129: Compositions and methods for controlling genetically engineered organisms
Patent 6124130: Microbial catalyst for desulfurization of fossil fuels
(CHEMISTRY: MOLECULAR BIOLOGY AND MICROBIOLOGY : PROCESS OF UTILIZING AN ENZYME OR MICRO-ORGANISM TO DESTROY HAZARDOUS OR TOXIC WASTE, LIBERATE, SEPARATE, OR PURIFY A PREEXISTING COMPOUND OR COMPOSITION THEREFORE; CLEANING OBJECTS OR TEXTILES : Petroleum oil or shale oil treating : Desulfurizing : Cellulose (e.g., plant fibers, etc.))
Patent 6124131: Mutant hypoxia inducible factor-1 HIF-1
(CHEMISTRY: MOLECULAR BIOLOGY AND MICROBIOLOGY : ANIMAL CELL, PER SE (E.G., CELL LINES, ETC.); COMPOSITION THEREOF; PROCESS OF PROPAGATING, MAINTAINING OR PRESERVING AN ANIMAL CELL OR COMPOSITION THEREOF; PROCESS OF ISOLATING OR SEPARATING AN ANIMAL CELL OR COMPOSITION THEREOF; PROCESS OF PREPARING A COMPOSITION CONTAINING AN ANIMAL CELL; CULTURE MEDIA THEREFORE : Recovery or purification)
Patent 6124132: Use of anti-HIV IGA antibodies for producing immunological protection against the human immunodeficiency virus
(CHEMISTRY: MOLECULAR BIOLOGY AND MICROBIOLOGY : ANIMAL CELL, PER SE (E.G., CELL LINES, ETC.); COMPOSITION THEREOF; PROCESS OF PROPAGATING, MAINTAINING OR PRESERVING AN ANIMAL CELL OR COMPOSITION THEREOF; PROCESS OF ISOLATING OR SEPARATING AN ANIMAL CELL OR COMPOSITION THEREOF; PROCESS OF PREPARING A COMPOSITION CONTAINING AN ANIMAL CELL; CULTURE MEDIA THEREFORE : Animal cell, per se, expressing immunoglobulin, antibody, or fragment thereof : Immunoglobulin or antibody binds a microorganism or normal or mutant component or product thereof (e.g., animal cell, cell surface antigen, secretory product, etc.) : Binds a virus or component or product thereof (e.g., virus associated antigen, etc.) : Binds a retrovirus or component or product thereof (e.g., HIV, LAV, HTLV, etc.) : From aspergillus)
Patent 6124133: Antisense inhibition of fra-1 expression
(CHEMISTRY: MOLECULAR BIOLOGY AND MICROBIOLOGY : ANIMAL CELL, PER SE (E.G., CELL LINES, ETC.); COMPOSITION THEREOF; PROCESS OF PROPAGATING, MAINTAINING OR PRESERVING AN ANIMAL CELL OR COMPOSITION THEREOF; PROCESS OF ISOLATING OR SEPARATING AN ANIMAL CELL OR COMPOSITION THEREOF; PROCESS OF PREPARING A COMPOSITION CONTAINING AN ANIMAL CELL; CULTURE MEDIA THEREFORE : Method of regulating cell metabolism or physiology : Human)
Patent 6124134: Glucose related measurement method and apparatus
(CHEMISTRY: ANALYTICAL AND IMMUNOLOGICAL TESTING : BIOLOGICAL CELLULAR MATERIAL TESTED : Acidity, basicity or neutralization number)
Patent 6124135: Method of determining an alkali ion
(CHEMISTRY: ANALYTICAL AND IMMUNOLOGICAL TESTING : METAL OR METAL CONTAINING : Li, Na, K, Rb, Cs, Fr, Be, Mg, Ca, Sr, Ba, Ra : Ge, Sn, Pb)
Patent 6124136: Method of monitoring compliance with methadone treatment program
(CHEMISTRY: ANALYTICAL AND IMMUNOLOGICAL TESTING : NITROGEN CONTAINING : Amine and quaternary ammonium : Plural nitrogen in the same ring (e.g., barbituates, creatinine, etc.))
Patent 6124137: Surface-enhanced photolabile attachment and release for desorption and detection of analytes
(CHEMISTRY: ANALYTICAL AND IMMUNOLOGICAL TESTING : PYROLYSIS, COMBUSTION, OR ELEVATED TEMPERATURE CONVERSION : Of an ionized gas)
Patent 6124138: Method for multiple analyte detection
(CHEMISTRY: ANALYTICAL AND IMMUNOLOGICAL TESTING : INVOLVING AN INSOLUBLE CARRIER FOR IMMOBILIZING IMMUNOCHEMICALS : Through a gel (e.g., Ouchterlony technique, etc.))
Patent 6124139: Method and apparatus for indirect agglutination immunoassay
(CHEMISTRY: ANALYTICAL AND IMMUNOLOGICAL TESTING : INVOLVING IMMUNE COMPLEX FORMED IN LIQUID PHASE : Separation of immune complex from unbound antigen or antibody : Involving precipitating reagent : Carrier is water suspendible particles)
Patent 6124140: Method for measuring features of a semiconductor device
(SEMICONDUCTOR DEVICE MANUFACTURING: PROCESS : INCLUDING CONTROL RESPONSIVE TO SENSED CONDITION : Electrical characteristic sensed : Chemical etching)
Patent 6124141: Non-destructive method and device for measuring the depth of a buried interface
(SEMICONDUCTOR DEVICE MANUFACTURING: PROCESS : WITH MEASURING OR TESTING : Electrical characteristic sensed)
Patent 6124142: Method for analyzing minute foreign substance elements
(SEMICONDUCTOR DEVICE MANUFACTURING: PROCESS : WITH MEASURING OR TESTING : Electrical characteristic sensed : Utilizing integral test element : Plasma etching)
Patent 6124143: Process monitor circuitry for integrated circuits
(SEMICONDUCTOR DEVICE MANUFACTURING: PROCESS : WITH MEASURING OR TESTING : Electrical characteristic sensed : Utilizing integral test element : Plasma etching)
Patent 6124144: Metal electrode mask in a method of fault failure analysis and characterization of semiconductor devices
(SEMICONDUCTOR DEVICE MANUFACTURING: PROCESS : WITH MEASURING OR TESTING : Electrical characteristic sensed : Utilizing integral test element : Plasma etching)
Patent 6124145: Micromachined gas-filled chambers and method of microfabrication
(SEMICONDUCTOR DEVICE MANUFACTURING: PROCESS : MAKING DEVICE OR CIRCUIT EMISSIVE OF NONELECTRICAL SIGNAL : Packaging (e.g., with mounting, encapsulating, etc.) or treatment of packaged semiconductor : Including device responsive to nonelectrical signal)
Patent 6124146: Resistless device fabrication method
(SEMICONDUCTOR DEVICE MANUFACTURING: PROCESS : MAKING DEVICE OR CIRCUIT EMISSIVE OF NONELECTRICAL SIGNAL : Mesa formation : Multiple wavelength emissive)
Patent 6124147: Method for fabricating optoelectronic device in low-temperature deposition and thermal treatment
(SEMICONDUCTOR DEVICE MANUFACTURING: PROCESS : MAKING DEVICE OR CIRCUIT EMISSIVE OF NONELECTRICAL SIGNAL : Compound semiconductor : With epitaxial deposition of semiconductor in groove)
Patent 6124148: Method of manufacturing semiconductor acceleration sensor
(SEMICONDUCTOR DEVICE MANUFACTURING: PROCESS : MAKING DEVICE OR CIRCUIT RESPONSIVE TO NONELECTRICAL SIGNAL : Physical stress responsive : Having cantilever element : Packaging (e.g., with mounting, encapsulating, etc.) or treatment of packaged semiconductor)
Patent 6124149: Method of making stackable semiconductor chips to build a stacked chip module
(SEMICONDUCTOR DEVICE MANUFACTURING: PROCESS : PACKAGING (E.G., WITH MOUNTING, ENCAPSULATING, ETC.) OR TREATMENT OF PACKAGED SEMICONDUCTOR : Assembly of plural semiconductive substrates each possessing electrical device : Contact formation (i.e., metallization))
Patent 6124150: Transverse hybrid LOC package
(SEMICONDUCTOR DEVICE MANUFACTURING: PROCESS : PACKAGING (E.G., WITH MOUNTING, ENCAPSULATING, ETC.) OR TREATMENT OF PACKAGED SEMICONDUCTOR : Metallic housing or support : Lead frame : Utilizing a coating to perfect the dicing)
Patent 6124151: Plastic lead frames for semiconductor devices, packages including same, and methods of fabrication
(SEMICONDUCTOR DEVICE MANUFACTURING: PROCESS : PACKAGING (E.G., WITH MOUNTING, ENCAPSULATING, ETC.) OR TREATMENT OF PACKAGED SEMICONDUCTOR : Insulative housing or support : And encapsulating)
Patent 6124152: Method for fabricating cob type semiconductor package
(SEMICONDUCTOR DEVICE MANUFACTURING: PROCESS : PACKAGING (E.G., WITH MOUNTING, ENCAPSULATING, ETC.) OR TREATMENT OF PACKAGED SEMICONDUCTOR : Insulative housing or support : And encapsulating : Utilizing a coating to perfect the dicing)
Patent 6124153: Method for manufacturing a polysilicon TFT with a variable thickness gate oxide
(SEMICONDUCTOR DEVICE MANUFACTURING: PROCESS : MAKING FIELD EFFECT DEVICE HAVING PAIR OF ACTIVE REGIONS SEPARATED BY GATE STRUCTURE BY FORMATION OR ALTERATION OF SEMICONDUCTIVE ACTIVE REGIONS : On insulating substrate or layer (e.g., TFT, etc.) : Having insulated gate : Vertical channel)
Patent 6124154: Fabrication process for thin film transistors in a display or electronic device
(SEMICONDUCTOR DEVICE MANUFACTURING: PROCESS : MAKING FIELD EFFECT DEVICE HAVING PAIR OF ACTIVE REGIONS SEPARATED BY GATE STRUCTURE BY FORMATION OR ALTERATION OF SEMICONDUCTIVE ACTIVE REGIONS : On insulating substrate or layer (e.g., TFT, etc.) : Having insulated gate : Vertical channel)
Patent 6124155: Electro-optical device and thin film transistor and method for forming the same
(SEMICONDUCTOR DEVICE MANUFACTURING: PROCESS : MAKING FIELD EFFECT DEVICE HAVING PAIR OF ACTIVE REGIONS SEPARATED BY GATE STRUCTURE BY FORMATION OR ALTERATION OF SEMICONDUCTIVE ACTIVE REGIONS : On insulating substrate or layer (e.g., TFT, etc.) : Having insulated gate : Inverted transistor structure : Complementary field effect transistors)
Patent 6124156: Process for manufacturing a CMOS circuit with all-around dielectrically insulated source-drain regions
(SEMICONDUCTOR DEVICE MANUFACTURING: PROCESS : MAKING FIELD EFFECT DEVICE HAVING PAIR OF ACTIVE REGIONS SEPARATED BY GATE STRUCTURE BY FORMATION OR ALTERATION OF SEMICONDUCTIVE ACTIVE REGIONS : Having insulated gate (e.g., IGFET, MISFET, MOSFET, etc.) : Complementary insulated gate field effect transistors (i.e., CMOS) : Multiple parallel current paths (e.g., grid gate, etc.))
Patent 6124157: Integrated non-volatile and random access memory and method of forming the same
(SEMICONDUCTOR DEVICE MANUFACTURING: PROCESS : MAKING FIELD EFFECT DEVICE HAVING PAIR OF ACTIVE REGIONS SEPARATED BY GATE STRUCTURE BY FORMATION OR ALTERATION OF SEMICONDUCTIVE ACTIVE REGIONS : Having insulated gate (e.g., IGFET, MISFET, MOSFET, etc.) : Complementary insulated gate field effect transistors (i.e., CMOS) : And additional electrical device : Including insulated gate field effect transistor having gate surrounded by dielectric (i.e., floating gate) : Multiple doping steps)
Patent 6124158: Method of reducing carbon contamination of a thin dielectric film by using gaseous organic precursors, inert gas, and ozone to react with
(SEMICONDUCTOR DEVICE MANUFACTURING: PROCESS : MAKING FIELD EFFECT DEVICE HAVING PAIR OF ACTIVE REGIONS SEPARATED BY GATE STRUCTURE BY FORMATION OR ALTERATION OF SEMICONDUCTIVE ACTIVE REGIONS : Having insulated gate (e.g., IGFET, MISFET, MOSFET, etc.) : Complementary insulated gate field effect transistors (i.e., CMOS) : Gate insulator structure constructed of diverse dielectrics (e.g., MNOS, etc.) or of nonsilicon compound : Including passive device (e.g., resistor, capacitor, etc.))
Patent 6124159: Method for integrating high-voltage device and low-voltage device
(SEMICONDUCTOR DEVICE MANUFACTURING: PROCESS : MAKING FIELD EFFECT DEVICE HAVING PAIR OF ACTIVE REGIONS SEPARATED BY GATE STRUCTURE BY FORMATION OR ALTERATION OF SEMICONDUCTIVE ACTIVE REGIONS : Having insulated gate (e.g., IGFET, MISFET, MOSFET, etc.) : Complementary insulated gate field effect transistors (i.e., CMOS) : Including isolation structure : Recessed oxide formed by localized oxidation (i.e., LOCOS) : Having well structure of opposite conductivity type)
Patent 6124160: Semiconductor device and method for manufacturing the same
(SEMICONDUCTOR DEVICE MANUFACTURING: PROCESS : MAKING FIELD EFFECT DEVICE HAVING PAIR OF ACTIVE REGIONS SEPARATED BY GATE STRUCTURE BY FORMATION OR ALTERATION OF SEMICONDUCTIVE ACTIVE REGIONS : Having insulated gate (e.g., IGFET, MISFET, MOSFET, etc.) : Including passive device (e.g., resistor, capacitor, etc.) : Lateral bipolar transistor)
Patent 6124161: Method for fabricating a hemispherical silicon grain layer
(SEMICONDUCTOR DEVICE MANUFACTURING: PROCESS : MAKING FIELD EFFECT DEVICE HAVING PAIR OF ACTIVE REGIONS SEPARATED BY GATE STRUCTURE BY FORMATION OR ALTERATION OF SEMICONDUCTIVE ACTIVE REGIONS : Having insulated gate (e.g., IGFET, MISFET, MOSFET, etc.) : Including passive device (e.g., resistor, capacitor, etc.) : Lateral bipolar transistor)
Patent 6124162: Method for manufacturing cylindrical lower electrode of DRAM capacitor
(SEMICONDUCTOR DEVICE MANUFACTURING: PROCESS : MAKING FIELD EFFECT DEVICE HAVING PAIR OF ACTIVE REGIONS SEPARATED BY GATE STRUCTURE BY FORMATION OR ALTERATION OF SEMICONDUCTIVE ACTIVE REGIONS : Having insulated gate (e.g., IGFET, MISFET, MOSFET, etc.) : Including passive device (e.g., resistor, capacitor, etc.) : Lateral bipolar transistor)
Patent 6124163: Integrated chip multiplayer decoupling capacitors
(SEMICONDUCTOR DEVICE MANUFACTURING: PROCESS : MAKING FIELD EFFECT DEVICE HAVING PAIR OF ACTIVE REGIONS SEPARATED BY GATE STRUCTURE BY FORMATION OR ALTERATION OF SEMICONDUCTIVE ACTIVE REGIONS : Having insulated gate (e.g., IGFET, MISFET, MOSFET, etc.) : Including passive device (e.g., resistor, capacitor, etc.) : Lateral bipolar transistor)
Patent 6124164: Method of making integrated capacitor incorporating high K dielectric
(SEMICONDUCTOR DEVICE MANUFACTURING: PROCESS : MAKING FIELD EFFECT DEVICE HAVING PAIR OF ACTIVE REGIONS SEPARATED BY GATE STRUCTURE BY FORMATION OR ALTERATION OF SEMICONDUCTIVE ACTIVE REGIONS : Having insulated gate (e.g., IGFET, MISFET, MOSFET, etc.) : Including passive device (e.g., resistor, capacitor, etc.) : Capacitor : Having high dielectric constant insulator (e.g., Ta2O5, etc.) : Plural doping steps)
Patent 6124165: Method for making openings in a passivation layer over polycide fuses using a single mask while forming reliable tungsten via plugs on DRAMs
(SEMICONDUCTOR DEVICE MANUFACTURING: PROCESS : MAKING FIELD EFFECT DEVICE HAVING PAIR OF ACTIVE REGIONS SEPARATED BY GATE STRUCTURE BY FORMATION OR ALTERATION OF SEMICONDUCTIVE ACTIVE REGIONS : Having insulated gate (e.g., IGFET, MISFET, MOSFET, etc.) : Including passive device (e.g., resistor, capacitor, etc.) : Capacitor : Stacked capacitor : Including doping of semiconductive region)
Patent 6124166: Method of forming a lower electrode of a capacitor in a DRAM cell
(SEMICONDUCTOR DEVICE MANUFACTURING: PROCESS : MAKING FIELD EFFECT DEVICE HAVING PAIR OF ACTIVE REGIONS SEPARATED BY GATE STRUCTURE BY FORMATION OR ALTERATION OF SEMICONDUCTIVE ACTIVE REGIONS : Having insulated gate (e.g., IGFET, MISFET, MOSFET, etc.) : Including passive device (e.g., resistor, capacitor, etc.) : Capacitor : Stacked capacitor : Including texturizing storage node layer : Multiple doping steps)
Patent 6124167: Method for forming an etch mask during the manufacture of a semiconductor device
(SEMICONDUCTOR DEVICE MANUFACTURING: PROCESS : MAKING FIELD EFFECT DEVICE HAVING PAIR OF ACTIVE REGIONS SEPARATED BY GATE STRUCTURE BY FORMATION OR ALTERATION OF SEMICONDUCTIVE ACTIVE REGIONS : Having insulated gate (e.g., IGFET, MISFET, MOSFET, etc.) : Having additional gate electrode surrounded by dielectric (i.e., floating gate) : Capacitor)
Patent 6124168: Method for forming an asymmetric floating gate overlap for improved device performance in buried bit-line devices
(SEMICONDUCTOR DEVICE MANUFACTURING: PROCESS : MAKING FIELD EFFECT DEVICE HAVING PAIR OF ACTIVE REGIONS SEPARATED BY GATE STRUCTURE BY FORMATION OR ALTERATION OF SEMICONDUCTIVE ACTIVE REGIONS : Having insulated gate (e.g., IGFET, MISFET, MOSFET, etc.) : Having additional gate electrode surrounded by dielectric (i.e., floating gate) : Including elongated source or drain region disposed under thick oxide regions (e.g., buried or diffused bitline, etc.) : Tunneling insulator : Contacts formed by selective growth or deposition)
Patent 6124169: Contact structure and associated process for production of semiconductor electronic devices and in particular nonvolatile EPROM and flash EPROM
(SEMICONDUCTOR DEVICE MANUFACTURING: PROCESS : MAKING FIELD EFFECT DEVICE HAVING PAIR OF ACTIVE REGIONS SEPARATED BY GATE STRUCTURE BY FORMATION OR ALTERATION OF SEMICONDUCTIVE ACTIVE REGIONS : Having insulated gate (e.g., IGFET, MISFET, MOSFET, etc.) : Having additional gate electrode surrounded by dielectric (i.e., floating gate) : Including elongated source or drain region disposed under thick oxide regions (e.g., buried or diffused bitline, etc.) : Tunneling insulator : Contacts formed by selective growth or deposition)
Patent 6124170: Method for making flash memory
(SEMICONDUCTOR DEVICE MANUFACTURING: PROCESS : MAKING FIELD EFFECT DEVICE HAVING PAIR OF ACTIVE REGIONS SEPARATED BY GATE STRUCTURE BY FORMATION OR ALTERATION OF SEMICONDUCTIVE ACTIVE REGIONS : Having insulated gate (e.g., IGFET, MISFET, MOSFET, etc.) : Having additional gate electrode surrounded by dielectric (i.e., floating gate) : Having additional, nonmemory control electrode or channel portion (e.g., for accessing field effect transistor structure, etc.) : Including forming gate electrode as conductive sidewall spacer to another electrode : Contacts formed by selective growth or deposition)
Patent 6124171: Method of forming gate oxide having dual thickness by oxidation process
(SEMICONDUCTOR DEVICE MANUFACTURING: PROCESS : MAKING FIELD EFFECT DEVICE HAVING PAIR OF ACTIVE REGIONS SEPARATED BY GATE STRUCTURE BY FORMATION OR ALTERATION OF SEMICONDUCTIVE ACTIVE REGIONS : Having insulated gate (e.g., IGFET, MISFET, MOSFET, etc.) : Asymmetric : Introducing a dopant into the channel region of selected transistors)
Patent 6124172: Method of making a semiconductor device having source/drain structures with self-aligned heavily-doped and lightly-doped regions
(SEMICONDUCTOR DEVICE MANUFACTURING: PROCESS : MAKING FIELD EFFECT DEVICE HAVING PAIR OF ACTIVE REGIONS SEPARATED BY GATE STRUCTURE BY FORMATION OR ALTERATION OF SEMICONDUCTIVE ACTIVE REGIONS : Having insulated gate (e.g., IGFET, MISFET, MOSFET, etc.) : Self-aligned : Source or drain doping : Doping region beneath recessed oxide (e.g., to form chanstop, etc.))
Patent 6124173: Method for improved storage node isolation
(SEMICONDUCTOR DEVICE MANUFACTURING: PROCESS : MAKING FIELD EFFECT DEVICE HAVING PAIR OF ACTIVE REGIONS SEPARATED BY GATE STRUCTURE BY FORMATION OR ALTERATION OF SEMICONDUCTIVE ACTIVE REGIONS : Having insulated gate (e.g., IGFET, MISFET, MOSFET, etc.) : Self-aligned : Source or drain doping : Oblique implantation : Contacts formed by selective growth or deposition)
Patent 6124174: Spacer structure as transistor gate
(SEMICONDUCTOR DEVICE MANUFACTURING: PROCESS : MAKING FIELD EFFECT DEVICE HAVING PAIR OF ACTIVE REGIONS SEPARATED BY GATE STRUCTURE BY FORMATION OR ALTERATION OF SEMICONDUCTIVE ACTIVE REGIONS : Having insulated gate (e.g., IGFET, MISFET, MOSFET, etc.) : Self-aligned : Source or drain doping : Utilizing gate sidewall structure : Contacts formed by selective growth or deposition)
Patent 6124175: Rapid thermal anneal with a gaseous dopant species
(SEMICONDUCTOR DEVICE MANUFACTURING: PROCESS : MAKING FIELD EFFECT DEVICE HAVING PAIR OF ACTIVE REGIONS SEPARATED BY GATE STRUCTURE BY FORMATION OR ALTERATION OF SEMICONDUCTIVE ACTIVE REGIONS : Having insulated gate (e.g., IGFET, MISFET, MOSFET, etc.) : Self-aligned : Source or drain doping : Utilizing gate sidewall structure : Plural doping steps : Multiple doping steps)
Patent 6124176: Method of producing a semiconductor device with reduced fringe capacitance and short channel effect
(SEMICONDUCTOR DEVICE MANUFACTURING: PROCESS : MAKING FIELD EFFECT DEVICE HAVING PAIR OF ACTIVE REGIONS SEPARATED BY GATE STRUCTURE BY FORMATION OR ALTERATION OF SEMICONDUCTIVE ACTIVE REGIONS : Having insulated gate (e.g., IGFET, MISFET, MOSFET, etc.) : Self-aligned : Source or drain doping : Utilizing gate sidewall structure : Plural doping steps : Multiple doping steps)
Patent 6124177: Method for making deep sub-micron mosfet structures having improved electrical characteristics
(SEMICONDUCTOR DEVICE MANUFACTURING: PROCESS : MAKING FIELD EFFECT DEVICE HAVING PAIR OF ACTIVE REGIONS SEPARATED BY GATE STRUCTURE BY FORMATION OR ALTERATION OF SEMICONDUCTIVE ACTIVE REGIONS : Having insulated gate (e.g., IGFET, MISFET, MOSFET, etc.) : Self-aligned : Source or drain doping : Utilizing gate sidewall structure : Plural doping steps : Multiple doping steps)
Patent 6124178: Method of manufacturing MOSFET devices
(SEMICONDUCTOR DEVICE MANUFACTURING: PROCESS : MAKING FIELD EFFECT DEVICE HAVING PAIR OF ACTIVE REGIONS SEPARATED BY GATE STRUCTURE BY FORMATION OR ALTERATION OF SEMICONDUCTIVE ACTIVE REGIONS : Having insulated gate (e.g., IGFET, MISFET, MOSFET, etc.) : Radiation or energy treatment modifying properties of semiconductor regions of substrate (e.g., thermal, corpuscular, electromagnetic, etc.) : Source or drain doping)
Patent 6124179: Inverted dielectric isolation process
(SEMICONDUCTOR DEVICE MANUFACTURING: PROCESS : FORMING BIPOLAR TRANSISTOR BY FORMATION OR ALTERATION OF SEMICONDUCTIVE ACTIVE REGIONS : Having insulated gate (e.g., IGFET, MISFET, MOSFET, etc.))
Patent 6124180: BiCMOS process for counter doped collector
(SEMICONDUCTOR DEVICE MANUFACTURING: PROCESS : FORMING BIPOLAR TRANSISTOR BY FORMATION OR ALTERATION OF SEMICONDUCTIVE ACTIVE REGIONS : Forming base region of specified dopant concentration profile (e.g., inactive base region more heavily doped than active base region, etc.) : Self-aligned)
Patent 6124181: Method for manufacturing bipolar transistor capable of suppressing deterioration of transistor characteristics
(SEMICONDUCTOR DEVICE MANUFACTURING: PROCESS : FORMING BIPOLAR TRANSISTOR BY FORMATION OR ALTERATION OF SEMICONDUCTIVE ACTIVE REGIONS : Forming base region of specified dopant concentration profile (e.g., inactive base region more heavily doped than active base region, etc.) : Self-aligned)
Patent 6124182: Method of forming stacked capacitor
(SEMICONDUCTOR DEVICE MANUFACTURING: PROCESS : MAKING PASSIVE DEVICE (E.G., RESISTOR, CAPACITOR, ETC.) : Stacked capacitor : Including doping of semiconductive region)
Patent 6124183: Shallow trench isolation formation with simplified reverse planarization mask
(SEMICONDUCTOR DEVICE MANUFACTURING: PROCESS : FORMATION OF ELECTRICALLY ISOLATED LATERAL SEMICONDUCTIVE STRUCTURE : Grooved and refilled with deposited dielectric material : Refilling multiple grooves of different widths or depths : Recessed oxide laterally extending from groove)
Patent 6124184: Method for forming isolation region of semiconductor device
(SEMICONDUCTOR DEVICE MANUFACTURING: PROCESS : FORMATION OF ELECTRICALLY ISOLATED LATERAL SEMICONDUCTIVE STRUCTURE : Grooved and refilled with deposited dielectric material : Multiple insulative layers in groove : From doped insulator in groove)
Patent 6124185: Method for producing a semiconductor device using delamination
(SEMICONDUCTOR DEVICE MANUFACTURING: PROCESS : BONDING OF PLURAL SEMICONDUCTOR SUBSTRATES : Subsequent separation into plural bodies (e.g., delaminating, dicing, etc.) : And electrical conductor formation (i.e., metallization))
Patent 6124186: Deposition of device quality, low hydrogen content, hydrogenated amorphous silicon at high deposition rates with increased stability
(SEMICONDUCTOR DEVICE MANUFACTURING: PROCESS : FORMATION OF SEMICONDUCTIVE ACTIVE REGION ON ANY SUBSTRATE (E.G., FLUID GROWTH, DEPOSITION) : Amorphous semiconductor : Utilizing epitaxial lateral overgrowth)
Patent 6124187: Method of fabricating semiconductor device
(SEMICONDUCTOR DEVICE MANUFACTURING: PROCESS : INTRODUCTION OF CONDUCTIVITY MODIFYING DOPANT INTO SEMICONDUCTIVE MATERIAL : Ion implantation of dopant into semiconductor region : Including heat treatment : Using same conductivity-type dopant)
Patent 6124188: Semiconductor device and fabrication method using a germanium sacrificial gate electrode plug
(SEMICONDUCTOR DEVICE MANUFACTURING: PROCESS : COATING WITH ELECTRICALLY OR THERMALLY CONDUCTIVE MATERIAL : Insulated gate formation : Silicide)
Patent 6124189: Metallization structure and method for a semiconductor device
(SEMICONDUCTOR DEVICE MANUFACTURING: PROCESS : COATING WITH ELECTRICALLY OR THERMALLY CONDUCTIVE MATERIAL : Insulated gate formation : Combined with formation of ohmic contact to semiconductor region : Forming electrode of specified shape (e.g., slanted, etc.))
Patent 6124190: Method of manufacturing semiconductor device with silicide layer without short circuit
(SEMICONDUCTOR DEVICE MANUFACTURING: PROCESS : COATING WITH ELECTRICALLY OR THERMALLY CONDUCTIVE MATERIAL : Insulated gate formation : Possessing plural conductive layers (e.g., polycide) : Plural gate levels)
Patent 6124191: Self-aligned contact process using low density/low k dielectric
(SEMICONDUCTOR DEVICE MANUFACTURING: PROCESS : COATING WITH ELECTRICALLY OR THERMALLY CONDUCTIVE MATERIAL : Insulated gate formation : Having sidewall structure : Separated by insulator (i.e., floating gate))
Patent 6124192: Method for fabricating ultra-small interconnections using simplified patterns and sidewall contact plugs
(SEMICONDUCTOR DEVICE MANUFACTURING: PROCESS : COATING WITH ELECTRICALLY OR THERMALLY CONDUCTIVE MATERIAL : To form ohmic contact to semiconductive material : Having sidewall structure)
Patent 6124193: Raised tungsten plug antifuse and fabrication processes
(SEMICONDUCTOR DEVICE MANUFACTURING: PROCESS : COATING WITH ELECTRICALLY OR THERMALLY CONDUCTIVE MATERIAL : To form ohmic contact to semiconductive material : Selectively interconnecting (e.g., customization, wafer scale integration, etc.) : Using structure alterable to conductive state (i.e., antifuse) : Tunnelling dielectric layer)
Patent 6124194: Method of fabrication of anti-fuse integrated with dual damascene process
(SEMICONDUCTOR DEVICE MANUFACTURING: PROCESS : COATING WITH ELECTRICALLY OR THERMALLY CONDUCTIVE MATERIAL : To form ohmic contact to semiconductive material : Selectively interconnecting (e.g., customization, wafer scale integration, etc.) : Using structure alterable to conductive state (i.e., antifuse) : Tunnelling dielectric layer)
Patent 6124195: Utilization of die repattern layers for die internal connections
(SEMICONDUCTOR DEVICE MANUFACTURING: PROCESS : COATING WITH ELECTRICALLY OR THERMALLY CONDUCTIVE MATERIAL : To form ohmic contact to semiconductive material : Selectively interconnecting (e.g., customization, wafer scale integration, etc.) : Using structure alterable to nonconductive state (i.e., fuse) : Tunnelling dielectric layer)
Patent 6124196: Variable circuit connector and method of fabricating the same
(SEMICONDUCTOR DEVICE MANUFACTURING: PROCESS : COATING WITH ELECTRICALLY OR THERMALLY CONDUCTIVE MATERIAL : To form ohmic contact to semiconductive material : Contacting multiple semiconductive regions (i.e., interconnects) : Bump electrode)
Patent 6124197: Adjusting the size of conductive lines based upon contact size
(SEMICONDUCTOR DEVICE MANUFACTURING: PROCESS : COATING WITH ELECTRICALLY OR THERMALLY CONDUCTIVE MATERIAL : To form ohmic contact to semiconductive material : Contacting multiple semiconductive regions (i.e., interconnects) : Bump electrode)
Patent 6124198: Ultra high-speed chip interconnect using free-space dielectrics
(SEMICONDUCTOR DEVICE MANUFACTURING: PROCESS : COATING WITH ELECTRICALLY OR THERMALLY CONDUCTIVE MATERIAL : To form ohmic contact to semiconductive material : Contacting multiple semiconductive regions (i.e., interconnects) : Multiple metal levels, separated by insulating layer (i.e., multiple level metallization) : Including fusion of conductor)
Patent 6124199: Method for simultaneously forming a storage-capacitor electrode and interconnect
(SEMICONDUCTOR DEVICE MANUFACTURING: PROCESS : COATING WITH ELECTRICALLY OR THERMALLY CONDUCTIVE MATERIAL : To form ohmic contact to semiconductive material : Contacting multiple semiconductive regions (i.e., interconnects) : Multiple metal levels, separated by insulating layer (i.e., multiple level metallization) : Including fusion of conductor)
Patent 6124200: Method of fabricating an unlanded via
(SEMICONDUCTOR DEVICE MANUFACTURING: PROCESS : COATING WITH ELECTRICALLY OR THERMALLY CONDUCTIVE MATERIAL : To form ohmic contact to semiconductive material : Contacting multiple semiconductive regions (i.e., interconnects) : Multiple metal levels, separated by insulating layer (i.e., multiple level metallization) : Separating insulating layer is laminate or composite of plural insulating materials : By wire bonding)
Patent 6124201: Method for manufacturing semiconductors with self-aligning vias
(SEMICONDUCTOR DEVICE MANUFACTURING: PROCESS : COATING WITH ELECTRICALLY OR THERMALLY CONDUCTIVE MATERIAL : To form ohmic contact to semiconductive material : Contacting multiple semiconductive regions (i.e., interconnects) : Multiple metal levels, separated by insulating layer (i.e., multiple level metallization) : Having planarization step : Utilizing etch-stop layer : Silicide formation)
Patent 6124202: Methods of fabricating silicide layers and silicide contact structures in microelectronic devices
(SEMICONDUCTOR DEVICE MANUFACTURING: PROCESS : COATING WITH ELECTRICALLY OR THERMALLY CONDUCTIVE MATERIAL : To form ohmic contact to semiconductive material : Contacting multiple semiconductive regions (i.e., interconnects) : Diverse conductors : Having refractory group metal (i.e., titanium (Ti), zirconium (Zr), hafnium (Hf), vanadium (V), niobium (Nb), tantalum (Ta), chromium (Cr), molybdenum (Mo), tungsten (W), or alloy thereof) : Silicide : Silicide formation)
Patent 6124203: Method for forming conformal barrier layers
(SEMICONDUCTOR DEVICE MANUFACTURING: PROCESS : COATING WITH ELECTRICALLY OR THERMALLY CONDUCTIVE MATERIAL : To form ohmic contact to semiconductive material : Plural layered electrode or conductor : At least one layer forms a diffusion barrier : Having noble group metal (i.e., silver (Ag), gold (Au), platinum (Pt), palladium (Pd), rhodium (Rh), ruthenium (Ru), iridium (Ir), osmium (Os), or alloy thereof))
Patent 6124204: Method of removing copper oxide within via hole
(SEMICONDUCTOR DEVICE MANUFACTURING: PROCESS : COATING WITH ELECTRICALLY OR THERMALLY CONDUCTIVE MATERIAL : To form ohmic contact to semiconductive material : Copper of copper alloy conductor : Of refractory group metal (i.e., titanium (Ti), zirconium (Zr), hafnium (Hf), vanadium (V), niobium (Nb), tantalum (Ta), chromium (Cr), molybdenum (Mo), tungsten (W), or alloy thereof))
Patent 6124205: Contact/via force fill process
(SEMICONDUCTOR DEVICE MANUFACTURING: PROCESS : COATING WITH ELECTRICALLY OR THERMALLY CONDUCTIVE MATERIAL : To form ohmic contact to semiconductive material : Aluminum or aluminum alloy conductor : Of refractory group metal (i.e., titanium (Ti), zirconium (Zr), hafnium (Hf), vanadium (V), niobium (Nb), tantalum (Ta), chromium (Cr), molybdenum (Mo), tungsten (W), or alloy thereof))
Patent 6124206: Reduced pad erosion
(SEMICONDUCTOR DEVICE MANUFACTURING: PROCESS : CHEMICAL ETCHING : Combined with the removal of material by nonchemical means (e.g., ablating, abrading, etc.) : Combined mechanical and chemical material removal : Simultaneous (e.g., chemical-mechanical polishing, etc.) : Forming silicide)
Patent 6124207: Slurries for mechanical or chemical-mechanical planarization of microelectronic-device substrate assemblies, and methods and
(SEMICONDUCTOR DEVICE MANUFACTURING: PROCESS : CHEMICAL ETCHING : Combined with the removal of material by nonchemical means (e.g., ablating, abrading, etc.) : Combined mechanical and chemical material removal : Simultaneous (e.g., chemical-mechanical polishing, etc.) : Forming silicide)
Patent 6124208: Method of preventing bowing in a via formation process
(SEMICONDUCTOR DEVICE MANUFACTURING: PROCESS : CHEMICAL ETCHING : Combined with coating step : Coating of sidewall : Simultaneous (e.g., chemical-mechanical polishing, etc.))
Patent 6124209: Method for treating a surface of a silicon single crystal and a method for manufacturing a silicon single crystal thin film
(SEMICONDUCTOR DEVICE MANUFACTURING: PROCESS : CHEMICAL ETCHING : Vapor phase etching (i.e., dry etching) : Plural coating steps)
Patent 6124210: Method of cleaning surface of substrate and method of manufacturing semiconductor device
(SEMICONDUCTOR DEVICE MANUFACTURING: PROCESS : CHEMICAL ETCHING : Vapor phase etching (i.e., dry etching) : Plural coating steps)
Patent 6124211: Cleaning method
(SEMICONDUCTOR DEVICE MANUFACTURING: PROCESS : CHEMICAL ETCHING : Vapor phase etching (i.e., dry etching) : Utilizing electromagnetic or wave energy : Photo-induced etching : Utilizing particulate abradant)
Patent 6124212: High density plasma (HDP) etch method for suppressing micro-loading effects when etching polysilicon layers
(SEMICONDUCTOR DEVICE MANUFACTURING: PROCESS : CHEMICAL ETCHING : Vapor phase etching (i.e., dry etching) : Utilizing electromagnetic or wave energy : Photo-induced etching : Photo-induced plasma etching : Silicide)
Patent 6124213: Process of fabricating semiconductor device having ashing step for photo-resist mask in plasma produced from N.sub.x H.sub.y gas
(SEMICONDUCTOR DEVICE MANUFACTURING: PROCESS : CHEMICAL ETCHING : Vapor phase etching (i.e., dry etching) : Utilizing electromagnetic or wave energy : By creating electric field (e.g., plasma, glow discharge, etc.) : Photo-induced plasma etching)
Patent 6124214: Method and apparatus for ultrasonic wet etching of silicon
(SEMICONDUCTOR DEVICE MANUFACTURING: PROCESS : CHEMICAL ETCHING : Liquid phase etching : Differential etching of semiconductor substrate)
Patent 6124215: Apparatus and method for planarization of spin-on materials
(SEMICONDUCTOR DEVICE MANUFACTURING: PROCESS : COATING OF SUBSTRATE CONTAINING SEMICONDUCTOR REGION OR OF SEMICONDUCTOR SUBSTRATE : Utilizing reflow (e.g., planarization, etc.) : Silicon nitride)
Patent 6124216: Method of making intermetal dielectric layers having a low dielectric constant
(SEMICONDUCTOR DEVICE MANUFACTURING: PROCESS : COATING OF SUBSTRATE CONTAINING SEMICONDUCTOR REGION OR OF SEMICONDUCTOR SUBSTRATE : By reaction with substrate : Implantation of ion (e.g., to form ion amorphousized region prior to selective oxidation, reacting with substrate to form insulative region, etc.) : Silicide)
Patent 6124217: In-situ SiON deposition/bake/TEOS deposition process for reduction of defects in interlevel dielectric for integrated circuit interconnects
(SEMICONDUCTOR DEVICE MANUFACTURING: PROCESS : COATING OF SUBSTRATE CONTAINING SEMICONDUCTOR REGION OR OF SEMICONDUCTOR SUBSTRATE : Insulative material deposited upon semiconductive substrate : Reaction with silicon semiconductive region (e.g., oxynitride formation, etc.))
Patent 6124218: Method for cleaning wafer surface and a method for forming thin oxide layers
(SEMICONDUCTOR DEVICE MANUFACTURING: PROCESS : COATING OF SUBSTRATE CONTAINING SEMICONDUCTOR REGION OR OF SEMICONDUCTOR SUBSTRATE : Insulative material deposited upon semiconductive substrate : Silicon oxide formation : Using electromagnetic or wave energy (e.g., photo-induced deposition, plasma, etc.) : Using electromagnetic or wave energy)
Patent 6124219: Functional material containing volatile agent
(FABRIC (WOVEN, KNITTED, OR NONWOVEN TEXTILE OR CLOTH, ETC.) : COATED OR IMPREGNATED WOVEN, KNIT, OR NONWOVEN FABRIC WHICH IS NOT (A) ASSOCIATED WITH ANOTHER PREFORMED LAYER OR FIBER LAYER OR, (B) WITH RESPECT TO WOVEN AND KNIT, CHARACTERIZED, RESPECTIVELY, BY A PARTICULAR OR DIFFERENTIAL WEAVE OR KNIT, WHEREIN THE COATING OR IMPREGNATION IS NEITHER A FOAMED MATERIAL NOR A FREE METAL OR ALLOY LAYER : Coated or impregnated natural fiber fabric (e.g., cotton, wool, silk, linen, etc.) : Coated or impregnated cellulosic fiber fabric : Coating or impregnation contains natural gum, rosin, natural oil, or wax : At least one coating or impregnation functions to fix pigments or particles on the surface of a coating or impregnation)
Patent 6124220: Laminated board and process for production thereof
(FABRIC (WOVEN, KNITTED, OR NONWOVEN TEXTILE OR CLOTH, ETC.) : COATED OR IMPREGNATED WOVEN, KNIT, OR NONWOVEN FABRIC WHICH IS NOT (A) ASSOCIATED WITH ANOTHER PREFORMED LAYER OR FIBER LAYER OR, (B) WITH RESPECT TO WOVEN AND KNIT, CHARACTERIZED, RESPECTIVELY, BY A PARTICULAR OR DIFFERENTIAL WEAVE OR KNIT, WHEREIN THE COATING OR IMPREGNATION IS NEITHER A FOAMED MATERIAL NOR A FREE METAL OR ALLOY LAYER : Coated or impregnated inorganic fiber fabric : Coating or impregnation contains epoxy polymer or copolymer or polyether : Vinyl acetate polymer or copolymer)
Patent 6124221: Article of clothing having antibacterial, antifungal, and antiyeast properties
(FABRIC (WOVEN, KNITTED, OR NONWOVEN TEXTILE OR CLOTH, ETC.) : WOVEN FABRIC (I.E., WOVEN STRAND OR STRIP MATERIAL) : Including a free metal or alloy constituent : Metal or metal-coated strand : Coating or impregnation includes particulate material other than fiber)
Patent 6124222: Multi layer headliner with polyester fiber and natural fiber layers
(FABRIC (WOVEN, KNITTED, OR NONWOVEN TEXTILE OR CLOTH, ETC.) : NONWOVEN FABRIC (I.E., NONWOVEN STRAND OR FIBER MATERIAL) : Including an additional nonwoven fabric : Separate nonwoven fabric layers comprise chemically different strand or fiber material : Needled)
Patent 6124223: .beta.-quartz-based glass-ceramics
(COMPOSITIONS: CERAMIC : CERAMIC COMPOSITIONS : Devitrified glass-ceramics : Silica containing crystalline phase (e.g., stuffed quartz, crystobalite, etc.) :)
Patent 6124224: High temperature sealing glass
(COMPOSITIONS: CERAMIC : CERAMIC COMPOSITIONS : Glass compositions, compositions containing glass other than those wherein glass is a bonding agent, or glass batch forming compositions : Enamels, glazes, or fusion seals (e.g., raw, fritted, or calcined ingredients) : Fusion seals (frit plus material other than glass) : Magnesium aluminosilicate (e.g., cordierite, etc.))
Patent 6124225: Cutting tools and wear resistant articles and material for same
(COMPOSITIONS: CERAMIC : CERAMIC COMPOSITIONS : Refractory : Boride, silicide, nitride, oxynitride, carbonitride, or oxycarbonitride containing : Silicon aluminum oxynitride containing (i.e., SiAION compounds) : With rare earth or alkaline earth metal compound : With alkaline earth metal compound)
Patent 6124226: Process for forming a catalyst, catalyst support or catalyst precursor with compressed fluids
(CATALYST, SOLID SORBENT, OR SUPPORT THEREFOR: PRODUCT OR PROCESS OF MAKING : FORMING OR TREATING A SPHERE, PROCESS ONLY : Forming other than by liquid immersion :)
Patent 6124227: Hydrocarbon conversion catalyst composition and processes therefor and therewith
(CATALYST, SOLID SORBENT, OR SUPPORT THEREFOR: PRODUCT OR PROCESS OF MAKING : ZEOLITE OR CLAY, INCLUDING GALLIUM ANALOGS : And additional AL or Si containing component : Steam)
Patent 6124228: Mazzite supported catalyst
(CATALYST, SOLID SORBENT, OR SUPPORT THEREFOR: PRODUCT OR PROCESS OF MAKING : ZEOLITE OR CLAY, INCLUDING GALLIUM ANALOGS : And additional AL or Si containing component : Zeolite : With control of oxygen content in oxidation gas)
Patent 6124229: Process for the preparation of metallocene catalyst systems on inert support material using gas phase reactor
(CATALYST, SOLID SORBENT, OR SUPPORT THEREFOR: PRODUCT OR PROCESS OF MAKING : CATALYST OR PRECURSOR THEREFOR : Plural component system comprising A - Group I to IV metal hydride or organometallic compound - and B - Group IV to VIII metal, lanthanide or actinde compound - (i.e., alkali metal, Ag, Au, Cu, alkaline earth metal, Be, Mg, Zn, Cd, Hg, Sc, Y, Al, Ga, In, Tl, Ti, Zn, Hf, Ge, Sn or Pb hydride or organometallic compound and Ti, Zr, Hf, Ge, Sn, Pb, V, Nb, Ta, As, Sb, Bi, Cr, Mo, W, Po, Mn, Tc, Re, Iron group, Platinum group, atomic number 57 to 71 inclusive or atomic number 89 or higher compound) : Utilizing ammonium ions)
Patent 6124230: Polymerization catalyst systems, their production and use
(CATALYST, SOLID SORBENT, OR SUPPORT THEREFOR: PRODUCT OR PROCESS OF MAKING : CATALYST OR PRECURSOR THEREFOR : Plural component system comprising A - Group I to IV metal hydride or organometallic compound - and B - Group IV to VIII metal, lanthanide or actinde compound - (i.e., alkali metal, Ag, Au, Cu, alkaline earth metal, Be, Mg, Zn, Cd, Hg, Sc, Y, Al, Ga, In, Tl, Ti, Zn, Hf, Ge, Sn or Pb hydride or organometallic compound and Ti, Zr, Hf, Ge, Sn, Pb, V, Nb, Ta, As, Sb, Bi, Cr, Mo, W, Po, Mn, Tc, Re, Iron group, Platinum group, atomic number 57 to 71 inclusive or atomic number 89 or higher compound) : Component A metal is Group IA, IIA or IIIA and component B metal is Group IVB to VIIB or VIII (i.e., alkali metal, alkaline earth Metal, Be, Mg, Al, Ga, In or Tl and Ti, Zr, Hf, V, Nb, Ta, Cr, Mo, W, Mn, Tc, Re, iron Group or Platinum group) (e.g., Ziegler Catalyst, etc.) : Preparing catalyst or precursor : Utilizing water or compound containing hydroxy bonded to carbon :)
Patent 6124231: Supported catalyst system, processes for its preparation, and its use for the polymerization of olefins
(CATALYST, SOLID SORBENT, OR SUPPORT THEREFOR: PRODUCT OR PROCESS OF MAKING : CATALYST OR PRECURSOR THEREFOR : Organic compound containing : Organic compound including carbon-metal bond : And a third component C (i.e., an additive other than a saturated hydrocarbon or an aromatic hydrocarbon free of aliphatic or cycloaliphatic unsaturation))
Patent 6124232: Method for preparing an acidic solid oxide
(CATALYST, SOLID SORBENT, OR SUPPORT THEREFOR: PRODUCT OR PROCESS OF MAKING : CATALYST OR PRECURSOR THEREFOR : Metal, metal oxide or metal hydroxide : Of Group VI (i.e., Cr, Mo, W or Po) : And Group IV metal containing (i.e., Ti, Zr, Hf, Ge, Sn or Pb) : Zinc)
Patent 6124233: Highly active and selective catalysts for the production of unsaturated nitriles, methods of making and using the same
(CATALYST, SOLID SORBENT, OR SUPPORT THEREFOR: PRODUCT OR PROCESS OF MAKING : CATALYST OR PRECURSOR THEREFOR : Metal, metal oxide or metal hydroxide : Of Group VI (i.e., Cr, Mo, W or Po) : And Group V metal containing (i.e., V, Nb, Ta, As, Sb or Bi) : Vanadium containing : Platinum or palladium)
Patent 6124234: Catalyst with fine-particle dispersion of the active component
(CATALYST, SOLID SORBENT, OR SUPPORT THEREFOR: PRODUCT OR PROCESS OF MAKING : CATALYST OR PRECURSOR THEREFOR : Metal, metal oxide or metal hydroxide : Of Group VIII (i.e., iron or platinum group) : Of platinum group metal and of iron group (i.e., Ru, Rh, Pd, Os, Ir, or Pt and Fe, Co or Ni) : And Group III metal containing (i.e., Sc, Y, Al, Ga, In or Tl))
Patent 6124235: Accelerator system for crosslinking polymers which harden on exposure to the moisture in air
(CATALYST, SOLID SORBENT, OR SUPPORT THEREFOR: PRODUCT OR PROCESS OF MAKING : CATALYST OR PRECURSOR THEREFOR : Metal, metal oxide or metal hydroxide : Of Group IV (i.e., Ti, Zr, Hf, Ge, Sn or Pb) : Of silver)
Patent 6124236: Direct thermal printable film and laminate
(RECORD RECEIVER HAVING PLURAL INTERACTIVE LEAVES OR A COLORLESS COLOR FORMER, METHOD OF USE, OR DEVELOPER THEREFOR : HAVING A COLORLESS COLOR-FORMER, DEVELOPER THEREFOR, OR METHOD OF USE : Method of use, kit, or combined with marking instrument or organ :)
Patent 6124237: Orange dye mixture for thermal color proofing
(RECORD RECEIVER HAVING PLURAL INTERACTIVE LEAVES OR A COLORLESS COLOR FORMER, METHOD OF USE, OR DEVELOPER THEREFOR : HAVING PLURAL INTERACTIVE LEAVES : Spatial relationship specified between color-former and developer)
Patent 6124238: Pink dye for thermal color proofing
(RECORD RECEIVER HAVING PLURAL INTERACTIVE LEAVES OR A COLORLESS COLOR FORMER, METHOD OF USE, OR DEVELOPER THEREFOR : HAVING PLURAL INTERACTIVE LEAVES : Spatial relationship specified between color-former and developer)
Patent 6124239: Orange dye mixture for thermal color proofing
(RECORD RECEIVER HAVING PLURAL INTERACTIVE LEAVES OR A COLORLESS COLOR FORMER, METHOD OF USE, OR DEVELOPER THEREFOR : HAVING PLURAL INTERACTIVE LEAVES : Spatial relationship specified between color-former and developer)
Patent 6124240: Combinations of sulfonylurea herbicides and safeners
(PLANT PROTECTING AND REGULATING COMPOSITIONS : ANTIDOTES (E.G., SAFENERS, ANTAGONISTS, ETC.) : Hetero ring containing antidote : Hetero ring is six-membered including nitrogen :)
Patent 6124241: Method for increasing plant productivity using glutamic acid and glycolic acid
(PLANT PROTECTING AND REGULATING COMPOSITIONS : PLANT GROWTH REGULATING COMPOSITIONS (E.G., HERBICIDES, ETC.) : Plural active ingredients : Active ingredient contains -C(=X)X-, wherein the X`s are the same or diverse chalcogens : Nitrogen or halogen attached indirectly to the carbon of the -C(=X)X- group by acyclic nonionic bonding : With an active ingredient containing nitrogen, other than as nitro or nitroso, wherein the nitrogen is attached directly or indirectly to carbon by nonionic bonding)
Patent 6124242: Herbicidal compositions and processes based on ferrodoxin:NADP reductase inhibitors
(PLANT PROTECTING AND REGULATING COMPOSITIONS : PLANT GROWTH REGULATING COMPOSITIONS (E.G., HERBICIDES, ETC.) : Abscission agent, defoliant, or desiccant : Hetero ring containing active ingredient : Hetero ring is five-membered having two or more ring hetero atoms of which at least one is nitrogen : Ring chalcogen in the hetero ring : 1,2-diazines (e.g., pyridazones, etc.))
Patent 6124243: Method of controlling graminaceous weeds
(PLANT PROTECTING AND REGULATING COMPOSITIONS : PLANT GROWTH REGULATING COMPOSITIONS (E.G., HERBICIDES, ETC.) : Organic active compound containing : Hetero ring containing : Acyclic urea or thiourea bonded directly to ring carbon of the hetero ring (i.e., HNH-C(=X)-NH-, wherein X is sulfur or oxygen and substitution may be made for hydrogen only) : Sulfonyl bonded directly to the urea or thiourea nitrogen (e.g., N-phenylsulfonyl-N`- pyridinylureas, etc.) : The hetero ring consists of two nitrogens and four carbons : Additional hetero ring containing :)
Patent 6124244: Clear brine drill-in fluid
(EARTH BORING, WELL TREATING, AND OIL FIELD CHEMISTRY : EARTH BORING : Contains organic component : Organic component is carbohydrate or derivative thereof (e.g., sugar or gum, such as galactomannan, xanthan, etc.) or carboxylic acid ester of an alcohol which has five or more hydroxy groups bonded directly to carbons : Carbohydrate is starch or derivative thereof : Includes metal compound other than an alkali or alkaline earth metal compound (e.g., Al, Cr, Fe, Mn, Cu, etc.))
Patent 6124245: Drilling fluid additive and process therewith
(EARTH BORING, WELL TREATING, AND OIL FIELD CHEMISTRY : EARTH BORING : Contains organic component : Organic component is solid synthetic resin : Resin is polymer derived from ethylenic monomers only (e.g., maleic, itaconic, etc.) : Polymer derived from acrylic acid monomer or derivative : Nitrogen is attached directly or indirectly to the acrylic acid monomer or derivative by nonionic bonding (e.g., acrylamide, acrylonitrile, etc.) :)
Patent 6124246: High temperature epoxy resin compositions, additives and methods
(EARTH BORING, WELL TREATING, AND OIL FIELD CHEMISTRY : WELL TREATING : Contains organic component : Organic component is solid synthetic resin : Ester is higher fatty or carboxylic acid ester (e.g., sorbitan oleate, etc.))
Patent 6124247: Use of borated compounds for the improvement of the compatibility of lubricating oils with fluorocarbon elastomers
(SOLID ANTI-FRICTION DEVICES, MATERIALS THEREFOR, LUBRICANT OR SEPARANT COMPOSITIONS FOR MOVING SOLID SURFACES, AND MISCELLANEOUS MINERAL OIL COMPOSITIONS : LUBRICANTS OR SEPARANTS FOR MOVING SOLID SURFACES AND MISCELLANEOUS MINERAL OIL COMPOSITIONS (E.G., WATER CONTAINING, ETC.) : Organic compound containing boron : Carbonyl containing : Oxygen and nitrogen bonded directly to the same carbon atom or carbon chain (e.g., borated alkanolamines, etc.))
Patent 6124248: Organic lubricants and coolants
(SOLID ANTI-FRICTION DEVICES, MATERIALS THEREFOR, LUBRICANT OR SEPARANT COMPOSITIONS FOR MOVING SOLID SURFACES, AND MISCELLANEOUS MINERAL OIL COMPOSITIONS : LUBRICANTS OR SEPARANTS FOR MOVING SOLID SURFACES AND MISCELLANEOUS MINERAL OIL COMPOSITIONS (E.G., WATER CONTAINING, ETC.) : Protein, carbohydrate, lignin, plant matter of indeterminate structure, or their reaction product of indeterminate structure : Carbon or hydrogen bonded directly to the silicon)
Patent 6124249: Viscosity improvers for lubricating oil compositions
(SOLID ANTI-FRICTION DEVICES, MATERIALS THEREFOR, LUBRICANT OR SEPARANT COMPOSITIONS FOR MOVING SOLID SURFACES, AND MISCELLANEOUS MINERAL OIL COMPOSITIONS : LUBRICANTS OR SEPARANTS FOR MOVING SOLID SURFACES AND MISCELLANEOUS MINERAL OIL COMPOSITIONS (E.G., WATER CONTAINING, ETC.) : Organic -C(=O)O- compound : Specified compound wherein the single bonded oxygen is bonded oxygen is bonded directly to an additional carbon, which carbon may be single bonded to any atom but may be multiple bonded only to carbon (i.e., specified carboxylic acid ester) : Plural -C(=O)O- groups attached directly or indirectly to each other by nonionic bonding (e.g., estolides of hydroxy carboxylic acids, etc.) : Polymer of alpha, beta-olefinically unsaturated carboxylate monomer (e.g., polymethylmethacrylate, etc.) : Olefin or alpha, beta-olefinically unsaturated carboxylate is an additional monomer of the polymer (e.g., fumarate-ethylene or fumarate-acrylate copolymers, etc.))
Patent 6124250: Method of making highly alkaline solid cleaning compositions
(CLEANING COMPOSITIONS FOR SOLID SURFACES, AUXILIARY COMPOSITIONS THEREFOR, OR PROCESSES OF PREPARING THE COMPOSITIONS : CLEANING COMPOSITIONS OR PROCESSES OF PREPARING (E.G., SODIUM BISULFATE COMPONENT, ETC.) : Carboxylic or thiocarboxylic ester function in the component)
Patent 6124251: Toilet bowl cleaning tablet
(CLEANING COMPOSITIONS FOR SOLID SURFACES, AUXILIARY COMPOSITIONS THEREFOR, OR PROCESSES OF PREPARING THE COMPOSITIONS : CLEANING COMPOSITIONS OR PROCESSES OF PREPARING (E.G., SODIUM BISULFATE COMPONENT, ETC.) : For cleaning a specific substrate or removing a specific contaminant (e.g., for smoker`s pipe, etc.) : For toilet bowl or urinal : Phenol, cyclic carbonate, or soap component)
Patent 6124252: Multipurpose scale removing chemical compound
(CLEANING COMPOSITIONS FOR SOLID SURFACES, AUXILIARY COMPOSITIONS THEREFOR, OR PROCESSES OF PREPARING THE COMPOSITIONS : CLEANING COMPOSITIONS OR PROCESSES OF PREPARING (E.G., SODIUM BISULFATE COMPONENT, ETC.) : For cleaning a specific substrate or removing a specific contaminant (e.g., for smoker`s pipe, etc.) : For removing foreign matter from surface carrying a protective or ornamental coating, finish, or adhesively attached covering (e.g., from painted or papered wall, automobile body, etc.) : For manual dishwashing)
Patent 6124253: Aqueous composition for low-temperature metal-cleaning and method of use
(CLEANING COMPOSITIONS FOR SOLID SURFACES, AUXILIARY COMPOSITIONS THEREFOR, OR PROCESSES OF PREPARING THE COMPOSITIONS : CLEANING COMPOSITIONS OR PROCESSES OF PREPARING (E.G., SODIUM BISULFATE COMPONENT, ETC.) : For cleaning a specific substrate or removing a specific contaminant (e.g., for smoker`s pipe, etc.) : For bare metal surface (e.g., degreasing composition, etc.) : For use on nonferrous surface (e.g., aluminum, copper, tin plate, etc.) : Free organic or inorganic acid component)
Patent 6124255: Preparation comprising thiol-group-containing proteins
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Peptide containing (e.g., protein, peptones, fibrinogen, etc.) DOAI :)
Patent 6124256: Method for the prevention of a patient's fibroproliferative vasculopathy
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Peptide containing (e.g., protein, peptones, fibrinogen, etc.) DOAI :)
Patent 6124257: Method of treatment
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Peptide containing (e.g., protein, peptones, fibrinogen, etc.) DOAI :)
Patent 6124258: Iron-casein complex and process for preparing the same
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Peptide containing (e.g., protein, peptones, fibrinogen, etc.) DOAI : Heavy metal containing (e.g., hemoglobin, etc.) : With an additional active ingredient)
Patent 6124259: Method for treating ophthalmic disorders with IGFBP
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Peptide containing (e.g., protein, peptones, fibrinogen, etc.) DOAI : 25 or more peptide repeating units in known peptide chain structure : Monocyclic)
Patent 6124260: Inhibition of smooth muscle cell migration by Tenascin-C peptides
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Peptide containing (e.g., protein, peptones, fibrinogen, etc.) DOAI : 25 or more peptide repeating units in known peptide chain structure : Monocyclic)
Patent 6124261: Non-aqueous polar aprotic peptide formulations
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Peptide containing (e.g., protein, peptones, fibrinogen, etc.) DOAI : 25 or more peptide repeating units in known peptide chain structure : Monocyclic)
Patent 6124262: Compositions and methods for reducing adhesiveness of defective red blood cells
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Peptide containing (e.g., protein, peptones, fibrinogen, etc.) DOAI : 9 to 11 peptide repeating units in known peptide chain : Monocyclic)
Patent 6124263: Treatment of tumors by administration of growth hormone releasing compounds and their antagonists
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Peptide containing (e.g., protein, peptones, fibrinogen, etc.) DOAI : 5 or 6 peptide repeating units in known peptide chain : Monocyclic)
Patent 6124264: Heterocyclic compounds
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Peptide containing (e.g., protein, peptones, fibrinogen, etc.) DOAI : 2 peptide repeating units in known peptide chain : Monocyclic)
Patent 6124265: Method of making and cross-linking keratin-based films and sheets
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Peptide containing (e.g., protein, peptones, fibrinogen, etc.) DOAI : Produced by or extracted from animal tissue : Guanidine containing)
Patent 6124266: Sulpholipid composition and methods for treating skin disorders
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Carbohydrate (i.e., saccharide radical containing) DOAI : S-glycoside : Guanidine containing)
Patent 6124267: O-glycan inhibitors of selectin mediated inflammation derived from PSGL-1
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Carbohydrate (i.e., saccharide radical containing) DOAI : O-glycoside : Guanidine containing)
Patent 6124268: Natural antioxidant compositions, method for obtaining same and cosmetic, pharmaceutical and nutritional formulations thereof
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Carbohydrate (i.e., saccharide radical containing) DOAI : O-glycoside : Oxygen of the saccharide radical bonded directly to a nonsaccharide hetero ring or a polycyclo ring system which contains a nonsaccharide hetero ring :)
Patent 6124269: 2-Halo-6-O-substituted ketolide derivatives
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Carbohydrate (i.e., saccharide radical containing) DOAI : O-glycoside : Oxygen of the saccharide radical bonded directly to a nonsaccharide hetero ring or a polycyclo ring system which contains a nonsaccharide hetero ring : The hetero ring has 8 or more ring carbons : The hetero ring has exactly 13 ring carbons (e.g., erythromycin, etc.) :)
Patent 6124270: Use of a cationic amphipathic compound as a transfection agent, vaccine additive or drug
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Carbohydrate (i.e., saccharide radical containing) DOAI : N-glycoside : Nitrogen containing hetero ring : Polynucleotide (e.g., RNA, DNA, etc.) : Two saccharide radicals bonded through only oxygen to 4- and 6- positions of the cyclohexyl ring)
Patent 6124271: Method and conjugate for treating H. pylori infection
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Carbohydrate (i.e., saccharide radical containing) DOAI : N-glycoside : Nitrogen containing hetero ring : Polynucleotide (e.g., RNA, DNA, etc.) : Two saccharide radicals bonded through only oxygen to 4- and 6- positions of the cyclohexyl ring)
Patent 6124272: Antisense modulation of PDK-1 expression
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Carbohydrate (i.e., saccharide radical containing) DOAI : N-glycoside : Nitrogen containing hetero ring : Polynucleotide (e.g., RNA, DNA, etc.) : Two saccharide radicals bonded through only oxygen to 4- and 6- positions of the cyclohexyl ring)
Patent 6124273: Chitin hydrogels, methods of their production and use
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Carbohydrate (i.e., saccharide radical containing) DOAI : Polysaccharide : Chitin or derivative : Phosphorus containing (e.g., Vitamin B12, etc.))
Patent 6124274: Use of ascorbyl 2'-phosphates for stabilizing vitamin A and/or vitamin A derivatives in cosmetic and pharmaceutical preparations
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Phosphorus containing other than solely as part of an inorganic ion in an addition salt DOAI : Oxygen containing hetero ring : Oxygen in the hetero ring)
Patent 6124275: Methods and compositions for controlling a pest population
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Ortho-hydroxybenzoic acid (i.e., salicyclic acid) or derivative DOAI : Hetero ring containing)
Patent 6124276: Vitamin D derivative with substituent at the 2.beta.-position
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : 9,10-seco- cyclopentanohydrophenanthrene ring system (e.g., vitamin D, etc.) DOAI : Nitrogen containing (e.g., anilides, etc.))
Patent 6124277: Antithrombotic agents
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., O,S,Se or Te) or nitrogen as the only ring hetero atoms DOAI : Oxygen single bonded to a ring carbon of the cyclopentanohydrophenanthrene ring system)
Patent 6124278: Acylbenzoxazines for enhancing synaptic response
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., O,S,Se or Te) or nitrogen as the only ring hetero atoms DOAI : Hetero ring is four-membered and includes at least one ring nitrogen : Chalcogen double bonded directly to a ring carbon of the four-membered hetero ring which is adjacent to the ring nitrogen : Polycyclo ring system having the four-membered hetero ring as one of the cyclos : 7-position substituent contains hetero ring)
Patent 6124279: Therapeutic heterocycles
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., O,S,Se or Te) or nitrogen as the only ring hetero atoms DOAI : Hetero ring contains seven members including nitrogen, carbon and chalcogen : Chalcogen double bonded directly to a ring carbon which is adjacent to the ring nitrogen : The additional hetero ring contains ring nitrogen)
Patent 6124280: Substituted phenols as novel calcium channel blockers
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., O,S,Se or Te) or nitrogen as the only ring hetero atoms DOAI : Hetero ring is seven-membered consisting of one nitrogen and six carbons : Additional nitrogen containing hetero ring attached directly or indirectly to the seven-membered hetero ring by nonionic bonding)
Patent 6124281: Azolobenzazepine derivatives as neurologically active agents
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., O,S,Se or Te) or nitrogen as the only ring hetero atoms DOAI : Hetero ring is seven-membered consisting of one nitrogen and six carbons : Polycyclo ring system having the seven-membered hetero ring as one of the cyclos : Additional hetero atom in the polycyclo ring system : Two of the cyclos share at least three ring members (i.e., bridged))
Patent 6124282: Drug formulations
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., O,S,Se or Te) or nitrogen as the only ring hetero atoms DOAI : Hetero ring is six-membered and includes at least nitrogen and sulfur as ring members : 1,4-Thiazines : Chalcogen or nitrogen bonded directly to ring carbon of the six-membered hetero ring)
Patent 6124283: Substituted 1,2,3,4-tetrahydronaphthalene derivatives
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., O,S,Se or Te) or nitrogen as the only ring hetero atoms DOAI : Hetero ring is six-membered and includes at least nitrogen and sulfur as ring members : 1,4-Thiazines : Additional hetero ring attached directly or indirectly to the 1,4-thiazine by nonionic bonding : Phenothiazines (including hydrogenated))
Patent 6124284: Bicyclic amide derivatives and their use as muscle relaxants
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., O,S,Se or Te) or nitrogen as the only ring hetero atoms DOAI : Hetero ring is six-membered and includes at least nitrogen and oxygen as ring hetero atoms (e.g., monocyclic 1,2- and 1,3-oxazines, etc.) : Morpholines (i.e., fully hydrogenated 1,4- oxazines) : Bicyclo ring system having the six-membered hetero ring as one of the cyclos (e.g., 1,4-benzoxazines, etc.))
Patent 6124285: Indole-2,3-dione-3-oxime derivatives
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., O,S,Se or Te) or nitrogen as the only ring hetero atoms DOAI : Hetero ring is six-membered and includes at least nitrogen and oxygen as ring hetero atoms (e.g., monocyclic 1,2- and 1,3-oxazines, etc.) : Morpholines (i.e., fully hydrogenated 1,4- oxazines) : Additional hetero ring attached directly or indirectly to the morpholine ring by nonionic bonding : Polycyclo ring system having the additional hetero ring as one of the cyclos : Additional hetero ring attached directly or indirectly to the morpholines by nonionic bonding)
Patent 6124287: Imidazo[1,2-a]quinoxalin-4-amines active as adenosine antagonists, process for their preparation and pharmaceutical compositions thereof
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., O,S,Se or Te) or nitrogen as the only ring hetero atoms DOAI : Hetero ring is six-membered and includes at least nitrogen and oxygen as ring hetero atoms (e.g., monocyclic 1,2- and 1,3-oxazines, etc.) : Morpholines (i.e., fully hydrogenated 1,4- oxazines) : Additional hetero ring attached directly or indirectly to the morpholine ring by nonionic bonding : Polycyclo ring system having the additional hetero ring as one of the cyclos : Ring nitrogen shared by two of the cyclos : Polycyclo ring system having the additional hetero ring as one of the cyclos)
Patent 6124288: Xanthines and their therapeutic use
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., O,S,Se or Te) or nitrogen as the only ring hetero atoms DOAI : Hetero ring is six-membered and includes at least nitrogen and oxygen as ring hetero atoms (e.g., monocyclic 1,2- and 1,3-oxazines, etc.) : Morpholines (i.e., fully hydrogenated 1,4- oxazines) : Additional hetero ring attached directly or indirectly to the morpholine ring by nonionic bonding : Polycyclo ring system having the additional hetero ring as one of the cyclos : Bicyclo ring system having the additional hetero ring as one of the cyclos : Plural ring hetero atoms in the bicyclo ring system : Three or more ring hetero atoms in the bicyclo ring system : The additional hetero ring contains ring nitrogen)
Patent 6124289: Azolo triazines and pyrimidines
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., O,S,Se or Te) or nitrogen as the only ring hetero atoms DOAI : Hetero ring is six-membered consisting of three nitrogens and three carbon atoms : Nitrogen bonded directly to ring carbon of the hetero ring : Polycyclo ring system having the hetero ring as one of the cyclos)
Patent 6124290: Polycyclic phthalazine compounds and their use
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., O,S,Se or Te) or nitrogen as the only ring hetero atoms DOAI : Hetero ring is six-membered consisting of two nitrogens and four carbon atoms (e.g., pyridazines, etc.) : Polycyclo ring system having a 1,2- or 1,4-diazine as one of the cyclos : Polycyclo ring system having the hetero ring as one of the cyclos)
Patent 6124291: Pyrrolo[1,2-a]pyrazine-1,4-dione serine protease inhibitors
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., O,S,Se or Te) or nitrogen as the only ring hetero atoms DOAI : Hetero ring is six-membered consisting of two nitrogens and four carbon atoms (e.g., pyridazines, etc.) : Polycyclo ring system having a 1,2- or 1,4-diazine as one of the cyclos : 1,4-diazine as one of the cyclos : The chalcogen is bonded directly to two carbon atoms)
Patent 6124292: Synthetic analogs of ecteinascidin-743
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., O,S,Se or Te) or nitrogen as the only ring hetero atoms DOAI : Hetero ring is six-membered consisting of two nitrogens and four carbon atoms (e.g., pyridazines, etc.) : Polycyclo ring system having a 1,2- or 1,4-diazine as one of the cyclos : 1,4-diazine as one of the cyclos : At least three rings in the polycyclo ring system : The additional hetero ring is attached indirectly to the morpholine ring by an acyclic chain having a hetero atom as a chain member)
Patent 6124293: Semi-synthetic ecteinascidins
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., O,S,Se or Te) or nitrogen as the only ring hetero atoms DOAI : Hetero ring is six-membered consisting of two nitrogens and four carbon atoms (e.g., pyridazines, etc.) : Polycyclo ring system having a 1,2- or 1,4-diazine as one of the cyclos : 1,4-diazine as one of the cyclos : At least three rings in the polycyclo ring system : The additional hetero ring is attached indirectly to the morpholine ring by an acyclic chain having a hetero atom as a chain member)
Patent 6124294: Triazole compounds and the use thereof
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., O,S,Se or Te) or nitrogen as the only ring hetero atoms DOAI : Hetero ring is six-membered consisting of two nitrogens and four carbon atoms (e.g., pyridazines, etc.) : 1,4 diazines : Piperazines (i.e., fully hydrogenated 1,4-diazines) : Additional hetero ring attached directly or indirectly to the piperazine ring by nonionic bonding : The additional hetero ring is a 1,3 diazine ring : Five-membered nitrogen hetero ring attached directly or indirectly to the 1,3-diazine ring by nonionic bonding : The polycyclo ring system is quinazoline (including hydrogenated))
Patent 6124295: Compounds useful for inhibition of farnesyl protein transferase
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., O,S,Se or Te) or nitrogen as the only ring hetero atoms DOAI : Hetero ring is six-membered consisting of two nitrogens and four carbon atoms (e.g., pyridazines, etc.) : 1,4 diazines : Piperazines (i.e., fully hydrogenated 1,4-diazines) : Additional hetero ring attached directly or indirectly to the piperazine ring by nonionic bonding : The additional hetero ring is six-membered consisting of one nitrogen and five carbon atoms : Polycyclo ring system having the additional six-membered nitrogen hetero ring as one of the cyclos : Tricyclo ring system having the additional six-membered nitrogen hetero ring as one of the cyclos : Quinoxalines (including hydrogenated))
Patent 6124296: Arylglycinamide derivatives, methods of producing these substances and pharmaceutical compositions containing such compounds
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., O,S,Se or Te) or nitrogen as the only ring hetero atoms DOAI : Hetero ring is six-membered consisting of two nitrogens and four carbon atoms (e.g., pyridazines, etc.) : 1,4 diazines : Piperazines (i.e., fully hydrogenated 1,4-diazines) : Polycyclo ring system having the additional five-membered hetero ring as one of the cyclos)
Patent 6124297: .alpha.-unsaturated amines, their production and use
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., O,S,Se or Te) or nitrogen as the only ring hetero atoms DOAI : Hetero ring is six-membered consisting of two nitrogens and four carbon atoms (e.g., pyridazines, etc.) : 1,2 diazine attached directly or indirectly to an additional hetero ring by nonionic bonding : The additional hetero ring is a diazine : At least three rings in the polycyclo ring system)
Patent 6124298: Pyrazinedicarboxylic-acid derivatives as cell proliferation regulators
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., O,S,Se or Te) or nitrogen as the only ring hetero atoms DOAI : Hetero ring is six-membered consisting of two nitrogens and four carbon atoms (e.g., pyridazines, etc.) : 1,4 diazines : Piperazines (i.e., fully hydrogenated 1,4-diazines) : Nitrogen or -C(=X)-, wherein X is chalcogen, bonded directly to the piperazine ring : Ring oxygen in the additional hetero ring)
Patent 6124299: Calcitonin mimetics
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., O,S,Se or Te) or nitrogen as the only ring hetero atoms DOAI : Hetero ring is six-membered consisting of two nitrogens and four carbon atoms (e.g., pyridazines, etc.) : 1,4 diazines : Nitrogen or -C(=X)-, wherein X is chalcogen, bonded directly to ring carbon of the 1,4-diazine ring : Plural carbocyclic rings bonded directly to the same acyclic carbon atom which is attached directly or indirectly to the piperazine ring by nonionic bonding)
Patent 6124300: Aryloxy- and arylthio- fused pyridines and pyrimidines and derivatives
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., O,S,Se or Te) or nitrogen as the only ring hetero atoms DOAI : Hetero ring is six-membered consisting of three nitrogens and three carbon atoms : Morpholines (i.e., fully hydrogenated 1,4- oxazines))
Patent 6124301: Enhancement of the efficacy of triazolopyrimidines
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., O,S,Se or Te) or nitrogen as the only ring hetero atoms DOAI : Hetero ring is six-membered consisting of two nitrogens and four carbon atoms (e.g., pyridazines, etc.) : 1,3-diazines (e.g., pyrimidines, etc.) : Polycyclo ring system having 1,3-diazine as one of the cyclos : Bicyclo ring system having the 1,3-diazine as one of the cyclos : A ring nitrogen is shared by the two cyclos of the bicyclo ring system (e.g., pyrrolo [1,2-a]pyrimidine, imidazo[1,2-a]pyrimidine, etc.) : The shared ring nitrogen is bonded directly to a ring nitrogen of the second ring of the bicyclo ring system (e.g., pyrazolo[1,5-a]pyrimidine, etc.) : The second ring of the bicyclo ring system is a five-membered hetero ring including three ring nitrogens (e.g., triazolo[1,5-a]pyrimidine, etc.) : Quinolines (including hydrogenated))
Patent 6124302: 4,4-disubstituted-3,4-dihydro-2(1H)-quinazolinones useful as HIV reverse transcriptase inhibitors
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., O,S,Se or Te) or nitrogen as the only ring hetero atoms DOAI : Hetero ring is six-membered consisting of two nitrogens and four carbon atoms (e.g., pyridazines, etc.) : 1,3-diazines (e.g., pyrimidines, etc.) : Polycyclo ring system having 1,3-diazine as one of the cyclos : Bicyclo ring system having the 1,3-diazine as one of the cyclos : Quinazoline (including hydrogenated)(i.e., the second cyclo in the bicyclo ring system is an ortho-fused six-membered carbocycle) : Additional hetero ring attached directly or indirectly to the quinazoline ring system by nonionic bonding : Nitrogen bonded directly to ring carbon of the purine ring system (e.g., adenine, etc.))
Patent 6124303: Method for inhibiting neoplastic cells and related conditions by exposure to 9-substituted 2-(2-N-aloxyphenyl) purin-6-ones
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., O,S,Se or Te) or nitrogen as the only ring hetero atoms DOAI : Hetero ring is six-membered and includes at least nitrogen and oxygen as ring hetero atoms (e.g., monocyclic 1,2- and 1,3-oxazines, etc.) : Morpholines (i.e., fully hydrogenated 1,4- oxazines) : Additional hetero ring attached directly or indirectly to the morpholine ring by nonionic bonding : Polycyclo ring system having the additional hetero ring as one of the cyclos : Bicyclo ring system having the additional hetero ring as one of the cyclos : Plural ring hetero atoms in the bicyclo ring system : Three or more ring hetero atoms in the bicyclo ring system : The additional hetero ring contains ring nitrogen)
Patent 6124304: Penciclovir for the treatment of zoster associated pain
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., O,S,Se or Te) or nitrogen as the only ring hetero atoms DOAI : Hetero ring is six-membered consisting of two nitrogens and four carbon atoms (e.g., pyridazines, etc.) : 1,3-diazines (e.g., pyrimidines, etc.) : Polycyclo ring system having 1,3-diazine as one of the cyclos : Bicyclo ring system having the 1,3-diazine as one of the cyclos : Exactly four ring nitrogens in the bicyclo ring system : Purine (including hydrogenated) : Chalcogen bonded directly to a ring carbon of the purine ring system : Nitrogen bonded directly to a ring carbon of the purine ring system (e.g., guanine, etc.) : Chalcogen attached indirectly to the 9- position of the purine ring system by acyclic nonionic bonding : Having -C(=X)-, wherein X is chalcogen, bonded directly to carbon of the hetero ring of the quinoline ring system)
Patent 6124305: Use of N-(substituted glycyl)-2-cyanopyrrolidines in inhibiting dipeptidyl peptidase-IV
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., O,S,Se or Te) or nitrogen as the only ring hetero atoms DOAI : Hetero ring is six-membered consisting of two nitrogens and four carbon atoms (e.g., pyridazines, etc.) : 1,3-diazines (e.g., pyrimidines, etc.) : Pyrimidines with chalcogen bonded directly to a ring carbon of said pyrimidine moiety : Nitrogen bonded directly to the 1,3-diazine at 2-position : Two or more barbituric acid compounds or with an additional active ingredient or stabilizer)
Patent 6124306: Thioalkyl alpha substituted pyrimidine compounds
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., O,S,Se or Te) or nitrogen as the only ring hetero atoms DOAI : Hetero ring is six-membered consisting of two nitrogens and four carbon atoms (e.g., pyridazines, etc.) : 1,3-diazines (e.g., pyrimidines, etc.) : Pyrimidines with chalcogen bonded directly to a ring carbon of said pyrimidine moiety : Chalcogen bonded directly to pyrimidine at 2-position : The nitrogen is part of a hetero ring)
Patent 6124307: Nonnucleoside inhibitors of reverse transcriptase, composite binding pocket and methods for use thereof
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., O,S,Se or Te) or nitrogen as the only ring hetero atoms DOAI : Hetero ring is six-membered consisting of two nitrogens and four carbon atoms (e.g., pyridazines, etc.) : 1,3-diazines (e.g., pyrimidines, etc.) : Pyrimidines with chalcogen bonded directly to a ring carbon of said pyrimidine moiety : Chalcogen bonded directly to pyrimidine at 2-position : The nitrogen is part of a hetero ring)
Patent 6124308: Optically active phenyl pyrimidine derivatives as analgesic agent
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., O,S,Se or Te) or nitrogen as the only ring hetero atoms DOAI : Hetero ring is six-membered consisting of two nitrogens and four carbon atoms (e.g., pyridazines, etc.) : 1,3-diazines (e.g., pyrimidines, etc.) : Nitrogen bonded directly to the 1,3-diazine at 2-position by a single bond : Chalcogen bonded directly to pyrimidine at 2-position)
Patent 6124309: Method and pharmaceutical composition for regulating lipid concentration
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., O,S,Se or Te) or nitrogen as the only ring hetero atoms DOAI : Hetero ring is six-membered consisting of one nitrogen and five carbon atoms : 1,3-diazines (e.g., pyrimidines, etc.))
Patent 6124310: Enediyne compounds
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., O,S,Se or Te) or nitrogen as the only ring hetero atoms DOAI : Hetero ring is six-membered consisting of one nitrogen and five carbon atoms : Polycyclo ring system having the six-membered hetero ring as one of the cyclos : Pentacyclo ring system having the six-membered hetero ring as one of the cyclos : Two of the cyclos share at least three ring members (i.e., bridged) : The nitrogen is part of a hetero ring)
Patent 6124311: Methods for treating resistant tumors
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., O,S,Se or Te) or nitrogen as the only ring hetero atoms DOAI : Hetero ring is six-membered consisting of one nitrogen and five carbon atoms : Polycyclo ring system having the six-membered hetero ring as one of the cyclos : Pentacyclo ring system having the six-membered hetero ring as one of the cyclos : Ring nitrogen in the pentacyclo ring system is shared by five-membered cyclo and six-membered cyclo (e.g., vincamine, etc.) : One of the five cyclos is five-membered and includes ring chalcogen (e.g., codeine, morphine, etc.))
Patent 6124312: Heterocyclic compounds
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., O,S,Se or Te) or nitrogen as the only ring hetero atoms DOAI : Hetero ring is six-membered consisting of one nitrogen and five carbon atoms : Polycyclo ring system having the six-membered hetero ring as one of the cyclos : Tricyclo ring system having the six-membered hetero ring as one of the cyclos : Two of the cyclos share at least three ring carbons (i.e., bridged) (e.g., benzomorphans, etc.) : Plural ring nitrogens in the tricyclo ring system)
Patent 6124313: Imidazopyridine azolidinones
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., O,S,Se or Te) or nitrogen as the only ring hetero atoms DOAI : Hetero ring is six-membered consisting of one nitrogen and five carbon atoms : Polycyclo ring system having the six-membered hetero ring as one of the cyclos : Bicyclo ring system having the six-membered hetero ring as one of the cyclos : Plural hetero atoms in the bicyclo ring system : Plural ring nitrogens in the tricyclo ring system)
Patent 6124314: Osteoporosis compounds
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., O,S,Se or Te) or nitrogen as the only ring hetero atoms DOAI : Hetero ring is six-membered consisting of one nitrogen and five carbon atoms : Polycyclo ring system having the six-membered hetero ring as one of the cyclos : Bicyclo ring system having the six-membered hetero ring as one of the cyclos : Isoquinolines (including hydrogenated) : Exactly three ring nitrogens in the bicyclo ring system)
Patent 6124315: Method for potentiating primary drugs in treating multidrug resistant disease
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., O,S,Se or Te) or nitrogen as the only ring hetero atoms DOAI : Hetero ring is six-membered consisting of one nitrogen and five carbon atoms : Polycyclo ring system having the six-membered hetero ring as one of the cyclos : Bicyclo ring system having the six-membered hetero ring as one of the cyclos : Isoquinolines (including hydrogenated) : Plural isoquinoline ring systems attached directly or indirectly to each other by nonionic bonding : Three or more hetero atoms in the tricyclo ring system)
Patent 6124316: Compounds which are specific antagonists of the human NK3 receptor and their use as medicinal products and diagnostic tools
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., O,S,Se or Te) or nitrogen as the only ring hetero atoms DOAI : Hetero ring is six-membered consisting of one nitrogen and five carbon atoms : Piperidines : Plural piperidine rings : Quinolines (including hydrogenated))
Patent 6124317: 2-substituted piperidine analogs and their use as subtype-selective NMDA receptor antagonists
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., O,S,Se or Te) or nitrogen as the only ring hetero atoms DOAI : Hetero ring is six-membered consisting of one nitrogen and five carbon atoms : Piperidines : Additional ring containing : Quinolines (including hydrogenated))
Patent 6124318: Diphenylalkyl-tetrahydropyridines, process for their preparation, and pharmaceutical compositions containing them
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., O,S,Se or Te) or nitrogen as the only ring hetero atoms DOAI : Hetero ring is six-membered consisting of one nitrogen and five carbon atoms : Piperidines : Additional ring containing : Quinolines (including hydrogenated))
Patent 6124319: 3,3-disubstituted piperidines as modulators of chemokine receptor activity
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., O,S,Se or Te) or nitrogen as the only ring hetero atoms DOAI : Hetero ring is six-membered consisting of one nitrogen and five carbon atoms : Piperidines : Additional ring containing : The additional ring is a six-membered hetero ring consisting of one nitrogen and five carbon atoms : Additional hetero ring attached directly or indirectly to the quinoline ring system by nonionic bonding)
Patent 6124320: Methods for treating allergic disorders using norastemizole
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., O,S,Se or Te) or nitrogen as the only ring hetero atoms DOAI : Hetero ring is six-membered consisting of one nitrogen and five carbon atoms : Piperidines : Additional ring containing : The additional ring is one of the cyclos in a polycyclo ring system : Hetero ring in the polycyclo ring system : Plural hetero atoms in the polycyclo ring system : Plural ring nitrogens in the polycyclo ring system : Piperidinyl or tetrahydropyridyl)
Patent 6124321: Heteroaryl amines as novel acetyl cholinesterase inhibitors
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., O,S,Se or Te) or nitrogen as the only ring hetero atoms DOAI : Hetero ring is six-membered consisting of one nitrogen and five carbon atoms : Piperidines : Additional ring containing : The additional ring is one of the cyclos in a polycyclo ring system : Hetero ring in the polycyclo ring system : Plural hetero atoms in the polycyclo ring system : Plural ring nitrogens in the polycyclo ring system : Piperidinyl or tetrahydropyridyl)
Patent 6124322: Intravenous form of thalidomide for treating immunological diseases
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., O,S,Se or Te) or nitrogen as the only ring hetero atoms DOAI : Hetero ring is six-membered consisting of one nitrogen and five carbon atoms : Piperidines : Additional ring containing : The additional ring is one of the cyclos in a polycyclo ring system : Hetero ring in the polycyclo ring system : Ring nitrogen in the polycyclo ring system : Plural ring nitrogens in the polycyclo ring system)
Patent 6124323: 4-substituted piperidine analogs and their use as subtype selective NMDA receptor antagonists
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., O,S,Se or Te) or nitrogen as the only ring hetero atoms DOAI : Hetero ring is six-membered consisting of one nitrogen and five carbon atoms : Piperidines : Additional ring containing : Chalcogen bonded directly to ring carbon of the piperidine ring : Polycyclo ring system is tricyclo-carbocyclic)
Patent 6124324: Thiophene-ethyl thiourea compounds and use
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., O,S,Se or Te) or nitrogen as the only ring hetero atoms DOAI : Hetero ring is six-membered consisting of one nitrogen and five carbon atoms : Additional hetero ring containing : Chalcogen bonded directly to a ring carbon of the six-membered hetero ring)
Patent 6124325: Triazole antifungal agents
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., O,S,Se or Te) or nitrogen as the only ring hetero atoms DOAI : Hetero ring is six-membered consisting of one nitrogen and five carbon atoms : Additional hetero ring containing : Ring nitrogen in the additional hetero ring (e.g., oxazole, etc.) : Ring nitrogen in the polycyclo ring system)
Patent 6124326: Use of flupirtine for the prophylaxis and therapy of disorders which are associated with an unphysiologically high cell death rate
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., O,S,Se or Te) or nitrogen as the only ring hetero atoms DOAI : Hetero ring is six-membered consisting of one nitrogen and five carbon atoms : Nitrogen attached directly to the six-membered hetero ring by nonionic bonding : Nitrogen attached indirectly to the six-membered hetero ring by nonionic bonding)
Patent 6124327: HIV integrase inhibitors
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., O,S,Se or Te) or nitrogen as the only ring hetero atoms DOAI : Hetero ring is six-membered consisting of one nitrogen and five carbon atoms : Nitrogen attached directly to the six-membered hetero ring by nonionic bonding : Nitrogen attached indirectly to the six-membered hetero ring by nonionic bonding)
Patent 6124328: Methods and compositions for stimulating neurite growth
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., O,S,Se or Te) or nitrogen as the only ring hetero atoms DOAI : Hetero ring is six-membered consisting of one nitrogen and five carbon atoms : C=O bonded directly to the six-membered hetero ring : Plural acyclic nitrogens bonded directly to the same carbon or bonded directly to each other)
Patent 6124329: Metalloproteinase inhibitors
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., O,S,Se or Te) or nitrogen as the only ring hetero atoms DOAI : Five-membered hetero ring containing at least one nitrogen ring atom (e.g., 1,2,3-triazoles, etc.) : Plural ring nitrogens and a single chalcogen in the hetero ring : At 3-position)
Patent 6124330: N-[4-(Heteroarylmethyl)phenyl]-heteroarylamines
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., O,S,Se or Te) or nitrogen as the only ring hetero atoms DOAI : Five-membered hetero ring containing at least one nitrogen ring atom (e.g., 1,2,3-triazoles, etc.) : 1,3-thiazoles (including hydrogenated) : Oxadiazoles (including hydrogenated))
Patent 6124331: Selective NPY (Y5) antagonists (tricyclics)
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., O,S,Se or Te) or nitrogen as the only ring hetero atoms DOAI : Five-membered hetero ring containing at least one nitrogen ring atom (e.g., 1,2,3-triazoles, etc.) : 1,3-thiazoles (including hydrogenated) : Polycyclo ring system having the thiazole ring as one of the cyclos : C=O in a C(=O)O group (e.g., nicotinic acid, etc.))
Patent 6124332: Metalloproteinase inhibitors
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., O,S,Se or Te) or nitrogen as the only ring hetero atoms DOAI : Five-membered hetero ring containing at least one nitrogen ring atom (e.g., 1,2,3-triazoles, etc.) : 1,3-thiazoles (including hydrogenated) : Chalcogen bonded directly to ring carbon of the thiazole ring : Bicyclo ring system having the thiazole ring as one of the cyclos)
Patent 6124333: Metalloproteinase inhibitors
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., O,S,Se or Te) or nitrogen as the only ring hetero atoms DOAI : Five-membered hetero ring containing at least one nitrogen ring atom (e.g., 1,2,3-triazoles, etc.) : 1,3-thiazoles (including hydrogenated) : Chalcogen bonded directly to ring carbon of the thiazole ring : Bicyclo ring system having the thiazole ring as one of the cyclos)
Patent 6124334: Hetero-aromatic ring substituted phenyloxazolidinone antimicrobials
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., O,S,Se or Te) or nitrogen as the only ring hetero atoms DOAI : Five-membered hetero ring containing at least one nitrogen ring atom (e.g., 1,2,3-triazoles, etc.) : 1,3-oxazoles (including hydrogenated) : Chalcogen bonded directly to ring carbon of the oxazole ring : C=X bonded directly to the nitrogen which is bonded directly to the thiazole ring (X is chalcogen))
Patent 6124335: Fungicidal mixtures
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., O,S,Se or Te) or nitrogen as the only ring hetero atoms DOAI : Five-membered hetero ring containing at least one nitrogen ring atom (e.g., 1,2,3-triazoles, etc.) : 1,2,4-triazoles (including hydrogenated) : Additional chalcogen containing hetero ring)
Patent 6124336: Fungicide mixtures
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., O,S,Se or Te) or nitrogen as the only ring hetero atoms DOAI : Five-membered hetero ring containing at least one nitrogen ring atom (e.g., 1,2,3-triazoles, etc.) : 1,2,4-triazoles (including hydrogenated) : Additional chalcogen containing hetero ring)
Patent 6124337: Methods and formulations for modulating the human sexual response
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., O,S,Se or Te) or nitrogen as the only ring hetero atoms DOAI : Five-membered hetero ring containing at least one nitrogen ring atom (e.g., 1,2,3-triazoles, etc.) : 1,3-diazoles : Imidazoles : Chalcogen or nitrogen bonded indirectly to the imidazole ring by nonionic bonding : At imidazole ring carbon : Ring sulfur in the polycyclo ring system)
Patent 6124338: Imidazoles with serotonin receptor binding activity
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., O,S,Se or Te) or nitrogen as the only ring hetero atoms DOAI : Five-membered hetero ring containing at least one nitrogen ring atom (e.g., 1,2,3-triazoles, etc.) : 1,3-diazoles : 2-imidazolines : Chalcogen or nitrogen bonded indirectly to the imidazole ring by nonionic bonding)
Patent 6124339: Pesticidal 1-arylpyrazole derivatives
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., O,S,Se or Te) or nitrogen as the only ring hetero atoms DOAI : Five-membered hetero ring containing at least one nitrogen ring atom (e.g., 1,2,3-triazoles, etc.) : 1,2-diazoles : Pyrazoles : Chalcogen or nitrogen bonded directly to the pyrazole ring by nonionic bonding : At imidazole ring carbon)
Patent 6124340: Polymorphic compounds
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., O,S,Se or Te) or nitrogen as the only ring hetero atoms DOAI : Five-membered hetero ring containing at least one nitrogen ring atom (e.g., 1,2,3-triazoles, etc.) : The five-membered hetero ring consists of one nitrogen and four carbons : Polycyclo ring system having the five-membered hetero ring as one of the cyclos : Bicyclo ring system having the five-membered hetero ring as one of the cyclos : The bicyclo ring system consists of the five-membered hetero ring and a benzene ring (e.g., indole, etc.) : C=X bonded directly or indirectly by an acyclic carbon or carbon chain to ring carbon of the five-membered hetero ring (e.g., tryptophan, etc.) (X is chalcogen) : Plural chalcogens bonded directly to ring carbons of the five-membered hetero ring (e.g., phthalimide, etc.))
Patent 6124341: Endothelin antagonists
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., O,S,Se or Te) or nitrogen as the only ring hetero atoms DOAI : Five-membered hetero ring containing at least one nitrogen ring atom (e.g., 1,2,3-triazoles, etc.) : The five-membered hetero ring consists of one nitrogen and four carbons : Additional hetero ring : Bicyclo ring system having the five-membered hetero ring as one of the cyclos)
Patent 6124342: Pharmaceutical compositions containing pyrylium compounds, pyrylium salts and process for manufacturing a medicament containing the
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., O,S,Se or Te) or nitrogen as the only ring hetero atoms DOAI : Sulfur containing hetero ring : The hetero ring is six-membered : Carbocyclic ring bonded directly to the five-membered hetero ring)
Patent 6124343: Substituted phenyl compounds with a substituent having a thienyl ring
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., O,S,Se or Te) or nitrogen as the only ring hetero atoms DOAI : Sulfur containing hetero ring : The hetero ring is five-membered : Tricyclo ring system having the hetero ring as one of the cyclos)
Patent 6124344: Cyclopentane heptan(ene)oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., O,S,Se or Te) or nitrogen as the only ring hetero atoms DOAI : Sulfur containing hetero ring : The hetero ring is five-membered : Tricyclo ring system having the hetero ring as one of the cyclos)
Patent 6124345: Carbamoyl carboxylic acid amide oximes
(DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS : DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI) : Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., O,S,Se or Te) or nitrogen as the only ring hetero atoms DOAI : Sulfur containing hetero ring : The hetero ring is five-membered : Tricyclo ring system having the hetero ring as one of the cyclos)
|